<article xmlns:ns0="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0222393</article-id>
<article-id pub-id-type="publisher-id">PONE-D-19-20190</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Oxalates</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Gut bacteria</subject><subj-group><subject>Lactobacillus</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Ecology and environmental sciences</subject><subj-group><subject>Extremophiles</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Probiotics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Metabolomics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Lipid metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Lipid metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Metabolomic profiling of oxalate-degrading probiotic <italic>Lactobacillus acidophilus</italic> and <italic>Lactobacillus gasseri</italic></article-title>
<alt-title alt-title-type="running-head">Metabolomic profiling of <italic>Lactobacillus acidophilus</italic> and <italic>Lactobacillus gasseri</italic></alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" ns0:type="simple">
<name name-style="western">
<surname>Chamberlain</surname>
<given-names>Casey A.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing &#8211; original draft</role>
<role content-type="http://credit.casrai.org/">Writing &#8211; review &amp; editing</role>
<xref ref-type="aff" rid="aff001" />
</contrib>
<contrib contrib-type="author" ns0:type="simple">
<name name-style="western">
<surname>Hatch</surname>
<given-names>Marguerite</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing &#8211; review &amp; editing</role>
<xref ref-type="aff" rid="aff001" />
</contrib>
<contrib contrib-type="author" corresp="yes" ns0:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1623-009X</contrib-id>
<name name-style="western">
<surname>Garrett</surname>
<given-names>Timothy J.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing &#8211; review &amp; editing</role>
<xref ref-type="corresp" rid="cor001">*</xref>
<xref ref-type="aff" rid="aff001" />
</contrib>
</contrib-group>
<aff id="aff001"><addr-line>Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" ns0:type="simple">
<name name-style="western">
<surname>Motta</surname>
<given-names>Andrea</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1" />
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>National Research Council of Italy, ITALY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email ns0:type="simple">tgarrett@ufl.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>14</volume>
<issue>9</issue>
<elocation-id>e0222393</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-year>2019</copyright-year>
<copyright-holder>Chamberlain et al</copyright-holder>
<license ns0:href="http://creativecommons.org/licenses/by/4.0/" ns0:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" ns0:href="http://creativecommons.org/licenses/by/4.0/" ns0:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" ns0:href="info:doi/10.1371/journal.pone.0222393" />
<abstract>
<p>Oxalate, a ubiquitous compound in many plant-based foods, is absorbed through the intestine and precipitates with calcium in the kidneys to form stones. Over 80% of diagnosed kidney stones are found to be calcium oxalate. People who form these stones often experience a high rate of recurrence and treatment options remain limited despite decades of dedicated research. Recently, the intestinal microbiome has become a new focus for novel therapies. Studies have shown that select species of <italic>Lactobacillus</italic>, the most commonly included genus in modern probiotic supplements, can degrade oxalate <italic>in vitro</italic> and even decrease urinary oxalate in animal models of Primary Hyperoxaluria. Although the purported health benefits of <italic>Lactobacillus</italic> probiotics vary significantly between species, there is supporting evidence for their potential use as probiotics for oxalate diseases. Defining the unique metabolic properties of <italic>Lactobacillus</italic> is essential to define how these bacteria interact with the host intestine and influence overall health. We addressed this need by characterizing and comparing the metabolome and lipidome of the oxalate-degrading <italic>Lactobacillus acidophilus</italic> and <italic>Lactobacillus gasseri</italic> using ultra-high-performance liquid chromatography-high resolution mass spectrometry. We report many species-specific differences in the metabolic profiles of these <italic>Lactobacillus</italic> species and discuss potential probiotic relevance and function resulting from their differential expression. Also described is our validation of the oxalate-degrading ability of <italic>Lactobacillus acidophilus</italic> and <italic>Lactobacillus gasseri</italic>, even in the presence of other preferred carbon sources, measuring <italic>in vitro</italic> <sup>14</sup>C-oxalate consumption via liquid scintillation counting.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000062</institution-id>
<institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>2R01DK088892-05A1</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Hatch</surname>
<given-names>Marguerite</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>TG received 2R01DK088892-05A1 from the National Institutes of Health, <ext-link ext-link-type="uri" ns0:href="http://www.nih.gov" ns0:type="simple">www.nih.gov</ext-link>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="2" />
<table-count count="2" />
<page-count count="16" />
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>Data from this study is available at <ext-link ext-link-type="uri" ns0:href="http://www.metabolomicsworkbench.org/" ns0:type="simple">www.metabolomicsworkbench.org</ext-link> (data track ID 1809).</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Probiotics, defined by the World Health Organization (WHO) as &#8220;live microorganisms which when administered in adequate amounts, confer a health benefit on the host&#8221; [<xref ref-type="bibr" rid="pone.0222393.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0222393.ref002">2</xref>], have become widespread in the global health market. Often sold as foods or dietary supplements [<xref ref-type="bibr" rid="pone.0222393.ref003">3</xref>], many different probiotics exist that contain various cocktails of bacteria formulated to deliver specific health benefits ranging from immune system support [<xref ref-type="bibr" rid="pone.0222393.ref004">4</xref>], gastrointestinal regularity [<xref ref-type="bibr" rid="pone.0222393.ref005">5</xref>], serum cholesterol control [<xref ref-type="bibr" rid="pone.0222393.ref006">6</xref>], management of allergic diseases [<xref ref-type="bibr" rid="pone.0222393.ref007">7</xref>], and even relief of mental ailments such as anxiety and depression [<xref ref-type="bibr" rid="pone.0222393.ref008">8</xref>]. <italic>Lactobacillus</italic> is the most commonly-included genus of bacteria among typical probiotics [<xref ref-type="bibr" rid="pone.0222393.ref009">9</xref>]. Among the &gt;200 species of these Gram-positive, rod-shaped microorganisms known to exist [<xref ref-type="bibr" rid="pone.0222393.ref010">10</xref>], over 50 have been shown to sustainably colonize the intestines of healthy individuals [<xref ref-type="bibr" rid="pone.0222393.ref011">11</xref>], although they are believed to be a minority among the projected 40,000 species that comprise the intestinal microbiome [<xref ref-type="bibr" rid="pone.0222393.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0222393.ref013">13</xref>]. Proposed health benefits linked to <italic>Lactobacillus</italic> vary significantly by species and strain [<xref ref-type="bibr" rid="pone.0222393.ref014">14</xref>]. Recently, interest has turned to <italic>Lactobacillus</italic> regarding its ability to degrade oxalate in the intestine [<xref ref-type="bibr" rid="pone.0222393.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0222393.ref016">16</xref>].</p>
<p>Oxalate is a toxic compound introduced to humans exogenously through the diet and endogenously through natural metabolism in the liver [<xref ref-type="bibr" rid="pone.0222393.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0222393.ref018">18</xref>]. Dietary oxalate, not metabolized by humans [<xref ref-type="bibr" rid="pone.0222393.ref019">19</xref>], is absorbed across the intestinal epithelium and precipitates with calcium in excreted urine to form calcium oxalate kidney stones [<xref ref-type="bibr" rid="pone.0222393.ref020">20</xref>]. Among all urinary stones, which cost the economy over $10 billion annually to treat [<xref ref-type="bibr" rid="pone.0222393.ref021">21</xref>], approximately 80% are calcium oxalate [<xref ref-type="bibr" rid="pone.0222393.ref020">20</xref>]. Intestinal absorption of oxalate contributes significantly to urinary oxalate levels [<xref ref-type="bibr" rid="pone.0222393.ref017">17</xref>], a primary risk factor for nephrolithiasis [<xref ref-type="bibr" rid="pone.0222393.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0222393.ref020">20</xref>]. Consequently, increased attention has turned to intestinal bacteria that are able to degrade dietary oxalate for their potential as future probiotic therapies for urinary stone formation and other oxalate conditions, such as the rare genetic disease Primary Hyperoxaluria (PH) [<xref ref-type="bibr" rid="pone.0222393.ref022">22</xref>&#8211;<xref ref-type="bibr" rid="pone.0222393.ref025">25</xref>]. In this report, we emphasize <italic>Lactobacillus acidophilus</italic> (<italic>L</italic>. <italic>acidophilus</italic>) and <italic>Lactobacillus gasseri</italic> (<italic>L</italic>. <italic>gasseri</italic>), two well-studied, common probiotic species with unique associations to human health [<xref ref-type="bibr" rid="pone.0222393.ref026">26</xref>]. <italic>L</italic>. <italic>acidophilus</italic> is perhaps the most well-recognized probiotic species and has been associated with many health benefits, including lowering total and LDL cholesterol [<xref ref-type="bibr" rid="pone.0222393.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0222393.ref028">28</xref>], reduction of symptoms of gastrointestinal ailments such as diarrhea [<xref ref-type="bibr" rid="pone.0222393.ref029">29</xref>, <xref ref-type="bibr" rid="pone.0222393.ref030">30</xref>] and irritable bowel syndrome [<xref ref-type="bibr" rid="pone.0222393.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0222393.ref032">32</xref>], prevention of vaginal infections [<xref ref-type="bibr" rid="pone.0222393.ref033">33</xref>], alleviation of allergy symptoms [<xref ref-type="bibr" rid="pone.0222393.ref034">34</xref>], immune response regulation [<xref ref-type="bibr" rid="pone.0222393.ref035">35</xref>], and others. <italic>L</italic>. <italic>gasseri</italic>, although not as popular as <italic>L</italic>. <italic>acidophilus</italic>, has also been linked to many of these same health effects and is commonly studied for its purported association with weight loss [<xref ref-type="bibr" rid="pone.0222393.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0222393.ref037">37</xref>]. Both <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> have shown extraordinary potential as future probiotics for oxalate diseases. A previous report examining oxalate degradation by <italic>Lactobacillus</italic> indicates that out of 60 strains tested from 12 different species, strains of <italic>L</italic>. <italic>acidophilus and L</italic>. <italic>gasseri</italic> were most efficient in their ability to degrade oxalate <italic>in vitro</italic> [<xref ref-type="bibr" rid="pone.0222393.ref015">15</xref>]. Furthermore, every strain tested from both these species showed the capability to degrade oxalate, whereas other species have some strains which did not show degradation [<xref ref-type="bibr" rid="pone.0222393.ref015">15</xref>]. Perhaps the most significant evidence supporting the probiotic potential of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> is from a study by <italic>Hatch et al</italic> showing their ability to reduce 24-hr urinary oxalate excretion in a mouse model of PH by 34% and 32%, respectively, as a result of intestinal colonization [<xref ref-type="bibr" rid="pone.0222393.ref016">16</xref>]. This serves as compelling evidence that these microbes should be further investigated as potential probiotic remedies for diseases of oxalate. Elucidating the unique metabolic properties of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> is essential to complete our understanding of the role these species play as symbiotic inhabitants of the human intestine as well as the cumulative health effect potentially delivered to the host as a probiotic. This investigation serves to define the species-specific biochemical qualities of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> by characterizing and comparing their metabolomic and lipidomic profiles using ultra-high-performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS). For this study, we analyzed the same <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> isolates demonstrated by Hatch <italic>et al</italic> to significantly reduce PH-model urinary oxalate <italic>in vivo</italic>. We discuss both commonalities and significant differences in the expression of many compounds between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> as well as the potential biological and probiotic relevance of significant features. Additionally, we report our investigation and confirmation of the oxalate-degrading ability of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> in the presence of other preferred carbon sources measuring <italic>in vitro</italic> <sup>14</sup>C-oxalate consumption via liquid scintillation counting.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec003">
<title>Cell Culture, harvest, and Lysis</title>
<p>Pure cultures of <italic>L</italic>. <italic>acidophilus</italic> (ATCC<sup>TM</sup> 4357) and <italic>L</italic>. <italic>gasseri (</italic>ATCC<sup>TM</sup> 33323), the same isolates used by Hatch <italic>et al</italic> [<xref ref-type="bibr" rid="pone.0222393.ref016">16</xref>] obtained from the American Type Culture Collection (ATCC<sup>TM</sup>), were grown anaerobically from frozen 10% glycerol stocks at 37&#176;C in deMan, Rogosa and Sharpe (MRS) medium [<xref ref-type="bibr" rid="pone.0222393.ref015">15</xref>] supplemented with 20 mM oxalate and 1% glucose. Using a sterile syringe and needle, 8 anaerobic bottles containing 75 mL medium were each inoculated with 150 &#956;L glycerol stock for each species. Cultures were briefly shaken and allowed to incubate overnight at 37&#176;C for 24 hours. After incubation, cultures were harvested as individual biological replicates (n = 8 per species) using a process similar to our previously reported harvest and lysis method [<xref ref-type="bibr" rid="pone.0222393.ref038">38</xref>, <xref ref-type="bibr" rid="pone.0222393.ref039">39</xref>], which we describe here. Cultures were removed from the 37&#176;C incubator and centrifuged at 15,180&#215;g, 4&#176;C for 5 min to isolate bacterial pellets by discarding the conditioned medium supernatants. Pellets were washed 3 times by repeated resuspension in 6 mL 100 mM KH<sub>2</sub>PO<sub>4</sub>-based lysis buffer [<xref ref-type="bibr" rid="pone.0222393.ref040">40</xref>] followed by centrifugation. After the third wash, pellets were dried, weighed, resuspended in lysis buffer to a normalized concentration of 75 mg/mL, and transferred to 15 mL polypropylene (PP) vials. Cells were lysed by sonication while chilled in an ice bath using a Sonic Dismembrator Model 500 with a Branson Sonicator Probe (Thermo Fisher Scientific, Waltham, MA, USA) by the following method: 30% amplitude for 30 sec, 1 min cool-down, 60% amplitude for 30 sec, 2 min cool-down, 60% amplitude for 15 sec. Cell lysates were immediately frozen at &#8722;80&#176;C to ensure their stability and were briefly held frozen (approximately 1 month) until needed for extraction, all samples being stored for an equal period of time. In our experience, lysates of this nature suspended in KH<sub>2</sub>PO<sub>4</sub>-based lysis buffer are stable for metabolomics analyses for several years.</p>
</sec>
<sec id="sec004">
<title>Metabolite extraction</title>
<p>Wherever possible, during the metabolite and lipid extractions, samples were chilled on ice and protected from light. All reagents were LC-MS grade (Thermo Fisher Scientific). Metabolites were extracted by protein precipitation similarly to our previous work [<xref ref-type="bibr" rid="pone.0222393.ref038">38</xref>] using the following procedure. From each normalized cell lysate sample, 100 &#956;L was transferred to a 1.6 mL PP vial. Extraction blanks were also included for downstream data filtering using 100 &#956;L lysis buffer and were treated identically to biological samples. To each sample, 20 &#956;L of internal standard mixture (Acros Organics, Fairlawn, NJ, USA) in 0.1% formic acid in water was added followed by brief vortexing&#8211;Creatine(1-methyl-D<sub>3</sub>), D-Leucine-D<sub>10</sub>, L-Tryptophan-2,3,3-D<sub>3</sub>, L-Tyrosine-<sup>13</sup>C<sub>6</sub>, L-Leucine-<sup>13</sup>C<sub>6</sub>, L-Phenylalanine-<sup>13</sup>C<sub>6</sub>, N-BOC-L-tert-Leucine, N-BOC-L-Aspartic Acid, Succinic Acid-2,3,3,3-D<sub>4</sub>, Salicylic Acid-D<sub>6</sub>, Caffeine-(1-methyl-D3) (each 4 &#956;g/mL), Propionic Acid-<sup>13</sup>C<sub>3</sub> (8 &#956;g/mL), L-Tryptophan-2,3,3-D<sub>3</sub> (40 &#956;g/mL). Next, 800 &#956;L 8:1:1 acetonitrile:methanol:acetone was added to precipitate protein. Samples were again briefly vortexed and incubated on ice for 30 min. Protein content was pelleted by centrifugation at 20000&#215;g, 4&#176;C for 10 min, and 750 &#956;L supernatants were transferred to new 1.6 mL PP vials. Supernatants were dried under nitrogen at 30&#176;C and resuspended in 100 &#956;L 0.1% FA in water. Samples were centrifuged at 20000&#215;g, 4&#176;C for 10 min to pellet any remaining protein, and 50 &#956;L supernatants were transferred to glass LC vials for UHPLC-HRMS analysis.</p>
</sec>
<sec id="sec005">
<title>Lipid extraction</title>
<p>Lipids were extracted using a modified version of the Folch method [<xref ref-type="bibr" rid="pone.0222393.ref041">41</xref>] similarly to our previous work [<xref ref-type="bibr" rid="pone.0222393.ref038">38</xref>] using the following process which we describe in detail here. From each normalized cell lysate sample, 150 &#956;L was transferred to a 12 mL glass vial. Extraction blanks were included for downstream data filtering using 150 &#956;L lysis buffer and were treated identically to biological samples. To each sample, 20 &#956;L of internal standard mix (Avanti Polar Lipids, Alabaster, AL, USA) was added followed by brief vortexing&#8211;LPC(17:0), PC(17:0/17:0), PG(14:0/14:0), PE(15:0/15:0), PS(14:0/14:0), TG(15:0/15:0/15:0), PI(8:0), SM(d18:1/17:0), CER(d18:1/17:0), DG(14:0/14:0), CL(15:0(3)-16:1), SO(d17:1), PAzePC, CER(Glycosyl(<italic>&#946;</italic>) C12), BMP(14:0 (<italic>S</italic>,<italic>R</italic>)), LSM(d17:1), 5 &#956;g/mL each in 2:1 chloroform:methanol. Next, 400 &#956;L methanol was added to each sample followed by vortexing, then 800 &#956;L chloroform was added. Samples were vortexed and incubated on ice for 20 min, with vortexing at 10 and 20 min, followed by addition of 200 &#956;L water. Samples were briefly vortexed and incubated on ice for 10 min with vortexing at 5 and 10 min. Separation of the organic and aqueous layers was achieved by centrifugation at 3260&#215;<italic>g</italic>, 4&#176;C for 10 min. The organic (bottom) layer containing lipid content was transferred to a new 12 mL glass vial in two steps: first with removal of 800 &#956;L of the original organic layer, followed by another removal of 400 &#956;L after re-extracting the remaining aqueous layer with 400 &#956;L 2:1 chloroform:methanol by incubating on ice for 10 min and centrifugation at 3260&#215;<italic>g</italic>, 4&#176;C for 10 min. Lipid extracts were dried under nitrogen at 30&#176;C and reconstituted in 300 &#956;L isopropanol. Samples were centrifuged at 3260&#215;<italic>g</italic>, 4&#176;C for 10 min to pellet any residual protein, and 250 &#956;L supernatants were transferred to glass LC vials for UHPLC-HRMS analysis.</p>
</sec>
<sec id="sec006">
<title>Analytical instrumentation and methodology</title>
<p>Metabolomics and lipidomics analyses by UHPLC-HRMS were performed on a Thermo Q Exactive Orbitrap Mass Spectrometer with heated electrospray ionization source coupled to a Dionex Ultimate 3000 UHPLC system (Thermo Scientific). Parameters for the metabolomics analysis will be discussed first, followed by the lipidomics analysis. For the metabolomics analysis, reverse phase chromatography with gradient elution was employed using an ACE Excel 2 C18-PFP column (100mm&#8201;&#215;&#8201;2.1mm, 2.0&#956;m) (Advanced Chromatography Technologies, Ltd, Scotland). Gradient elution was performed with 0.1% formic acid in water as solvent A and acetonitrile as solvent B, at a flow rate of 0.35 mL/min, as such: 0&#8211;3 min: 100% A, 3&#8211;13 min: 100% &#8594; 20% A, 13&#8211;16.5 min: 20% A, 16.5&#8211;20 min: 100% A at 0.6 mL/min (column flush &amp; equilibration). Injection volume was 5 <italic>&#956;</italic>L. Data were acquired in both positive and negative ion mode by full scan analysis from <italic>m/z</italic> 70&#8211;1000 at 35000 mass resolution. For the lipidomics analysis, reverse phase chromatography was again employed using an AQUITY UPLC BEH C18 column (50mm&#8201;&#215;&#8201;2.1mm, 1.7&#956;m) (Waters Corporation, Milford, MA, USA) preceded by a corresponding VanGuard pre-column (Waters Corporation). Gradient elution was performed with 60:40 acetonitrile:water with 0.1% formic acid and 10mM ammonium formate as solvent A and 90:8:2 isopropanol:acetonitrile:water with 0.1% formic acid and 10mM ammonium formate as solvent B, at a flow rate of 0.5 mL/min, as such: 0&#8211;1 min: 80% A, 1&#8211;3 min: 80% &#8594; 70% A, 3&#8211;4 min: 70% &#8594; 55% A, 4&#8211;6 min: 55% &#8594; 40% A, 6&#8211;8 min: 40% &#8594; 35% A, 8&#8211;10 min: 35% A, 10&#8211;15 min: 35% &#8594; 10% A, 15&#8211;17 min: 10% &#8594; 2% A, 17&#8211;18 min: 2% A, 18&#8211;19 min: 2% &#8594; 80% A, 19&#8211;23 min: 80% A (column flush &amp; equilibration). Injection volume was 10 <italic>&#956;</italic>L. Data were acquired in both positive and negative ion mode by full scan (70000 mass resolution), data-dependent MS/MS (35000 mass resolution), and all-ion fragmentation MS/MS (70000 mass resolution) analyses from <italic>m/z</italic> 200&#8211;2200. Using pooled samples for each species, we employed iterative exclusion analysis, consisting of repeated data-dependent MS/MS analysis with successive exclusion of detected features, to allow detection of lower abundance lipid species in both positive (6 rounds) and negative (4 rounds) ion mode [<xref ref-type="bibr" rid="pone.0222393.ref042">42</xref>].</p>
</sec>
<sec id="sec007">
<title>Data processing</title>
<p>For quality control purposes, the performance of spiked internal standards was assessed in all samples. Excellent reproducibility was verified with standards showing relative standard deviations &lt; 10%. Parameters for the metabolomics data processing will be discussed first, followed by the lipidomics processing. Metabolomics data files were converted from .raw to .mzxml format using RawConverter [<xref ref-type="bibr" rid="pone.0222393.ref043">43</xref>]. MZmine 2 was employed for all processing involved in peak picking, chromatographic alignment, and metabolite identification [<xref ref-type="bibr" rid="pone.0222393.ref044">44</xref>]. Metabolites were identified by <italic>m/z</italic> (5 ppm) and elution time (&#177;0.2 min) matching to our method-specific internal library produced from pure analytical standards. Non-detected signals were replaced with half the minimum signal intensity value in the dataset [<xref ref-type="bibr" rid="pone.0222393.ref045">45</xref>]. Data were filtered to remove features with &#8805;10% signal contributed from the background as determined by comparison to the extraction blanks [<xref ref-type="bibr" rid="pone.0222393.ref046">46</xref>]. Signal intensities were median-normalized [<xref ref-type="bibr" rid="pone.0222393.ref047">47</xref>] and autoscaled [<xref ref-type="bibr" rid="pone.0222393.ref048">48</xref>]. For the lipidomics data, all processing, including file format conversion, peak picking, chromatographic alignment, and lipid identification (MS/MS fragmentation spectral matching to <italic>in silico</italic> databases) was performed using LipidMatch software [<xref ref-type="bibr" rid="pone.0222393.ref046">46</xref>]. Missing value replacement, as well as data filtration, normalization, and autoscaling, were performed similarly to the metabolomics data.</p>
</sec>
<sec id="sec008">
<title>Statistical analysis</title>
<p>MetaboAnalyst 4.0 was used for statistical analysis and figure generation [<xref ref-type="bibr" rid="pone.0222393.ref049">49</xref>]. All <italic>p</italic>-values were determined using the two-tailed, unpaired Student&#8217;s t-test assuming equal variance on the normalized, scaled dataset and adjusted for the false discovery rate using the Bonferroni-Holm correction [<xref ref-type="bibr" rid="pone.0222393.ref050">50</xref>]. In this report, we define significance with a <italic>p</italic>-value threshold of &#8804;0.001.</p>
</sec>
<sec id="sec009">
<title>Determination of oxalate degradation by liquid scintillation counting</title>
<p>Two 100 mL anaerobically sealed vials with 75 mL sterile MRS medium [<xref ref-type="bibr" rid="pone.0222393.ref015">15</xref>], supplemented with 20 mM oxalate and 1% glucose, were each spiked with 3 &#956;Ci of <sup>14</sup>C-oxalate (Vitrax, Placentia. CA, USA). Following a thorough mixing of the vial contents, two 100 &#956;L aliquots were removed from each 100 mL vial for liquid scintillation counting prior to inoculating with either <italic>L</italic>. <italic>acidophilus</italic> or <italic>L</italic>. <italic>gasseri</italic>. These vials were incubated at 37&#176;C for 3 days, after which time duplicate 100 &#956;L aliquots were removed from each culture and placed in liquid scintillation vials followed by acidification of the aliquot with HCl to induce volatilization of <sup>14</sup>CO<sub>2</sub> in the fume hood for a 24-hr period. Scintillation fluid was then added to the vials followed by liquid scintillation counting using a LS 6500 Multi-Purpose Scintillation Counter (Beckman Coulter, Brea, CA, USA). Final counts were compared to those pre-inoculation to quantify the remaining counts and calculate the percent-degradation of the original oxalate substrate by <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>.</p>
</sec>
</sec>
<sec id="sec010" sec-type="conclusions">
<title>Results and discussion</title>
<sec id="sec011">
<title>Metabolomics analysis</title>
<p>The refined metabolomics dataset consisted of a total of 2077 features detected between positive and negative ion mode. Significant differences between the metabolomes of these bacteria were observed at the global scale as well as the level of individual analytes. <xref ref-type="supplementary-material" rid="pone.0222393.s001">S1A Fig</xref> demonstrates clear separation of the general metabolomes of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> by Principal Component Analysis (PCA), mainly accounted for by PC1, with 76.8% of the variance described in 2 PCs. <xref ref-type="fig" rid="pone.0222393.g001">Fig 1</xref> portrays the high metabolomic diversity between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> with a volcano plot depicting the distribution of detected features by the magnitude and significance of their differential signal intensities. Among all detected features, 1508 (72.6%) showed a statistically significant difference in their relative intensities between species with 702 (46.6%) showing elevated expression in <italic>L</italic>. <italic>acidophilus</italic> and 806 (53.4%) showing elevated expression in <italic>L</italic>. <italic>gasseri</italic>. A total of 97 metabolites were identified by <italic>m/z</italic> and retention time matching to our internal library as listed in <xref ref-type="supplementary-material" rid="pone.0222393.s002">S1 Table</xref> with the magnitude and significance of the difference in their relative intensities between species. <xref ref-type="table" rid="pone.0222393.t001">Table 1</xref> details the top-25 significant identified metabolites. Among the most significant metabolites were several components of the Krebs Cycle, including succinic acid (<italic>p</italic> = 1.85x10<sup>-13</sup>, 4.3-fold higher intensity in <italic>L</italic>. <italic>acidophilus</italic>), fumaric acid (<italic>p</italic> = 6.25x10<sup>-12</sup>, 623.2-fold higher intensity in <italic>L</italic>. <italic>acidophilus</italic>), citric acid (<italic>p</italic> = 6.70x10<sup>-12</sup>, 139.9-fold higher intensity in <italic>L</italic>. <italic>gasseri</italic>), and malic acid (<italic>p</italic> = 6.74x10<sup>-10</sup>, 3.3-fold higher intensity in <italic>L</italic>. <italic>gasseri</italic>). It is worth mentioning that although these bacteria were grown under anaerobic conditions, leading us to expect the Krebs Cycle was not functioning, our results indicate a more complex metabolic process that is different between these two anaerobes. Such differential expression of these key metabolic compounds could have a variety of biological implications. Fumaric acid showed the greatest difference between species by magnitude. <italic>Lactobacillus</italic> has been noted in the literature due to its potential for industrial mass production of fumaric acid by fermentation [<xref ref-type="bibr" rid="pone.0222393.ref051">51</xref>]. In addition, fumaric acid is known to have an antimicrobial effect, likely due to acidifying the extracellular pH and making the environment inhospitable to competing microorganisms [<xref ref-type="bibr" rid="pone.0222393.ref052">52</xref>&#8211;<xref ref-type="bibr" rid="pone.0222393.ref054">54</xref>]. High production of fumaric acid for this purpose could be one reason behind the association between intestinal colonization by <italic>Lactobacillus</italic> and protective host immunity from pathogenic gut bacteria. Additionally, differential expression of fumaric acid between <italic>Lactobacillus</italic> species as seen in this experiment could result in dissimilar protective capacity between such species. Fumaric acid has also been suggested to serve as a terminal electron acceptor in electron transport chains (ETC) of several species of anaerobic bacteria, including lactic acid bacteria, for enhanced growth in the absence of oxygen [<xref ref-type="bibr" rid="pone.0222393.ref055">55</xref>, <xref ref-type="bibr" rid="pone.0222393.ref056">56</xref>]. The significantly different expression of fumaric acid between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> could suggest a differential reliance on this metabolic pathway, although to our knowledge, the utility of this proposed ETC in these species has not been reported or characterized in the literature. The high relative expression of citric acid by <italic>L</italic>. <italic>gasseri</italic>, serving as the second greatest difference by magnitude, is also interesting. Citric acid is a ubiquitous compound able to be produced by many different species of bacteria, some even extensively, under specific growth parameters [<xref ref-type="bibr" rid="pone.0222393.ref057">57</xref>]. Although the production of citric acid by <italic>Lactobacillus</italic> is not well-documented in the literature, several studies have shown that, under certain conditions, several species of <italic>Lactobacillus</italic> can use citric acid as an energy source and that the presence of citric acid in culture media has profound effects on their overall growth rate and metabolism [<xref ref-type="bibr" rid="pone.0222393.ref058">58</xref>&#8211;<xref ref-type="bibr" rid="pone.0222393.ref062">62</xref>]. The observed differential expression of citric acid between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> deserves further investigation. Gluconic acid (<italic>p</italic> = 1.17&#215;10<sup>&#8722;12</sup>, 56.2-fold higher intensity in <italic>L</italic>. <italic>acidophilus</italic>) and glucuronic acid (<italic>p</italic> = 1.41&#215;10<sup>&#8722;10</sup>, 11.9-fold higher intensity in <italic>L</italic>. <italic>acidophilus</italic>) also showed a significant difference between species. Gluconic acid and glucuronic acid are oxidation products of glucose, formed from oxidation at C1 and C6, respectively [<xref ref-type="bibr" rid="pone.0222393.ref063">63</xref>]. Both glucose derivatives have been shown to serve defensive functions in bacteria. Gluconic acid is produced by <italic>Pseudomonas</italic> as a key antifungal metabolite [<xref ref-type="bibr" rid="pone.0222393.ref064">64</xref>], which would translate as a potentially important role for an intestinal <italic>Lactobacillus</italic> species in terms of providing host immunity. Glucuronic acid plays a detoxification role in humans by binding to hormones, drugs, and toxins, forming glucuronides to facilitate their transport and elimination from the body. This process, known as glucuronidation, involves glycosidic bond formation of glucuronic acid from uridine diphosphate-glucuronic acid with these compounds by UDP-glucuronosyltransferases and is an important method by which harmful substances are solubilized and cleared from the body [<xref ref-type="bibr" rid="pone.0222393.ref065">65</xref>, <xref ref-type="bibr" rid="pone.0222393.ref066">66</xref>]. The production of glucuronic acid by <italic>Lactobacillus</italic> is indicative of a potential detoxification role these bacteria may play in the intestine. Since both gluconic acid and glucuronic acid were found to be elevated in <italic>L</italic>. <italic>acidophilus</italic>, it could be assumed that this species may be more effective in delivering their proposed health benefits to the human host as compared to <italic>L</italic>. <italic>gasseri</italic>, but this hypothesis requires further investigation to validate. Further work is needed to confirm the biological functionality of these discussed metabolites, as well as all other metabolites identified in this report, and characterize the nature of their differential expression between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>.</p>
<fig id="pone.0222393.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0222393.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Volcano plot depicting high metabolomic diversity between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>.</title>
<p>A total of 1508 features (72.6%) showing a statistically significant difference in their relative intensities between species with 702 (46.6%) showing elevated expression in <italic>L</italic>. <italic>acidophilus</italic> and 806 (53.4%) showing elevated expression in <italic>L</italic>. <italic>gasseri</italic>.</p>
</caption>
<graphic mimetype="image" position="float" ns0:href="info:doi/10.1371/journal.pone.0222393.g001" ns0:type="simple" />
</fig>
<table-wrap id="pone.0222393.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0222393.t001</object-id>
<label>Table 1</label> <caption><title>Top-25 identified metabolites of greatest significant difference in signal intensity between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>.</title></caption>
<alternatives>
<graphic id="pone.0222393.t001g" mimetype="image" position="float" ns0:href="info:doi/10.1371/journal.pone.0222393.t001" ns0:type="simple" />
<table>
<colgroup>
<col align="left" valign="middle" />
<col align="left" valign="middle" />
<col align="left" valign="middle" />
<col align="left" valign="middle" />
<col align="left" valign="middle" />
<col align="left" valign="middle" />
</colgroup>
<thead>
<tr style="border-top:thick">
<th align="center">Metabolite Species</th>
<th align="center">Exp Mass</th>
<th align="center">Ion</th>
<th align="center">Fold-Difference</th>
<th align="center">p-value</th>
<th align="center">Elevated Expression</th>
</tr>
</thead>
<tbody>
<tr style="border-top:thick">
<td align="center">Adenosine-5'-Diphosphate</td>
<td align="center">426.0230</td>
<td align="center">[M-H]-</td>
<td align="center">3.9</td>
<td align="center">4.10E-15</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">N-Acetylputrescine</td>
<td align="center">131.1179</td>
<td align="center">[M+H]+</td>
<td align="center">7.3</td>
<td align="center">7.49E-14</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Cytidine-5'-Diphosphate-glycerol</td>
<td align="center">476.0485</td>
<td align="center">[M-H]-</td>
<td align="center">12.0</td>
<td align="center">1.38E-13</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Succinic Acid</td>
<td align="center">117.0197</td>
<td align="center">[M-H]-</td>
<td align="center">4.3</td>
<td align="center">1.85E-13</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Gluconic Acid</td>
<td align="center">195.0511</td>
<td align="center">[M-H]-</td>
<td align="center">56.2</td>
<td align="center">1.17E-12</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Betaine</td>
<td align="center">118.0863</td>
<td align="center">[M+H]+</td>
<td align="center">2.0</td>
<td align="center">3.16E-12</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Fumaric Acid</td>
<td align="center">115.0038</td>
<td align="center">[M-H]-</td>
<td align="center">623.2</td>
<td align="center">6.25E-12</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Asparagine</td>
<td align="center">133.0607</td>
<td align="center">[M+H]+</td>
<td align="center">8.4</td>
<td align="center">9.41E-12</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Choline</td>
<td align="center">104.1070</td>
<td align="center">[M+H]+</td>
<td align="center">1.7</td>
<td align="center">2.16E-11</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">5-Hydroxymethyl-2-furaldehyde</td>
<td align="center">127.0391</td>
<td align="center">[M+H]+</td>
<td align="center">6.1</td>
<td align="center">4.39E-11</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Trimethyllysine</td>
<td align="center">189.1597</td>
<td align="center">[M+H]+</td>
<td align="center">1.8</td>
<td align="center">1.02E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Glucuronic Acid</td>
<td align="center">193.0356</td>
<td align="center">[M-H]-</td>
<td align="center">11.9</td>
<td align="center">1.41E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Glycerophosphocholine</td>
<td align="center">258.1098</td>
<td align="center">[M+H]+</td>
<td align="center">2.6</td>
<td align="center">1.65E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Aspartic Acid</td>
<td align="center">134.0447</td>
<td align="center">[M+H]+</td>
<td align="center">3.9</td>
<td align="center">1.76E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Methionine</td>
<td align="center">150.0584</td>
<td align="center">[M+H]+</td>
<td align="center">4.3</td>
<td align="center">2.99E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Lysine</td>
<td align="center">147.1127</td>
<td align="center">[M+H]+</td>
<td align="center">3.7</td>
<td align="center">4.97E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">3-Methyloxindole</td>
<td align="center">148.0757</td>
<td align="center">[M+H]+</td>
<td align="center">2.5</td>
<td align="center">8.53E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Carnitine</td>
<td align="center">162.1125</td>
<td align="center">[M+H]+</td>
<td align="center">1.5</td>
<td align="center">2.14E-09</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr style="border-bottom:thick">
<td align="center">Valine</td>
<td align="center">116.0717</td>
<td align="center">[M-H]-</td>
<td align="center">2.3</td>
<td align="center">2.46E-09</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
</tr>
<tr>
<td align="center">Citric Acid</td>
<td align="center">191.0200</td>
<td align="center">[M-H]-</td>
<td align="center">139.9</td>
<td align="center">6.70E-12</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
</tr>
<tr>
<td align="center">N-Acetylglutamic Acid</td>
<td align="center">190.0709</td>
<td align="center">[M+H]+</td>
<td align="center">3.9</td>
<td align="center">7.21E-12</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
</tr>
<tr>
<td align="center">3-Hydroxy-3-Methylglutaric Acid</td>
<td align="center">185.0421</td>
<td align="center">[M+Na]+</td>
<td align="center">2.7</td>
<td align="center">2.91E-11</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
</tr>
<tr>
<td align="center">Proline</td>
<td align="center">116.0706</td>
<td align="center">[M+H]+</td>
<td align="center">4.3</td>
<td align="center">6.00E-11</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
</tr>
<tr>
<td align="center">Malic Acid</td>
<td align="center">133.0145</td>
<td align="center">[M-H]-</td>
<td align="center">3.3</td>
<td align="center">6.74E-10</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
</tr>
<tr style="border-bottom:thick">
<td align="center">Nicotinic Acid</td>
<td align="center">124.0395</td>
<td align="center">[M+H]+</td>
<td align="center">10.7</td>
<td align="center">1.21E-09</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec012">
<title>Lipidomics analysis</title>
<p>As with the metabolomics analysis, significant differences between the lipidomes of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> were observed. <xref ref-type="supplementary-material" rid="pone.0222393.s001">S1B Fig</xref> demonstrates clear separation of the lipidomes of these bacteria by PCA, mainly accounted for by PC1, with 83.7% of the variance described in 2 PCs. A total of 71 lipid species were identified using a combination of MS/MS fragmentation and exact mass matching to <italic>in silico</italic> databases using LipidMatch open source software [<xref ref-type="bibr" rid="pone.0222393.ref046">46</xref>]. A complete list of identified lipids is presented in <xref ref-type="supplementary-material" rid="pone.0222393.s003">S2 Table</xref> along with the magnitude and significance of the difference in their relative intensities between species. Due to the nature of lipidomic analyses, a varying degree of overlap can sometimes present itself when making identifications because of the challenge of chromatographically resolving all the possible isomeric structures. Therefore, possible additional isomeric identifications to select lipids are provided. Among the 71 identified lipids, 59 showed a significant difference in their intensity between species with 27 showing elevated expression in <italic>L</italic>. <italic>acidophilus</italic> and 32 showing elevated expression in <italic>L</italic>. <italic>gasseri</italic>. The top-25 significant identified lipids are detailed in <xref ref-type="table" rid="pone.0222393.t002">Table 2</xref>. We observed that diacylglycerols (DGs), digalactosyldiacylglycerol (DGDGs), and phosphatidylglycerols (PGs) showed the greatest representation among the significant lipids. Regarding DGs, the nature of their fatty acyl chains was observed to differ significantly between species. DGs elevated in <italic>L</italic>. <italic>gasseri</italic> all possessed only 16 and 18-carbon tails, except DG(8:0/18:1). However, among the DGs elevated in <italic>L</italic>. <italic>acidophilus</italic>, a greater diversity was seen with 17, 18, 19, and 20-carbon tailed species. Among the most significant are DG(18:1/20:1) (<italic>p</italic> = 4.29&#215;10<sup>&#8722;12</sup>, 697.5-fold elevated intensity in <italic>L</italic>. <italic>acidophilus</italic>), DG(18:3/19:0) (<italic>p</italic> = 4.29&#215;10<sup>&#8722;12</sup>, 15.1-fold elevated intensity in <italic>L</italic>. <italic>acidophilus</italic>), and DG(18:2/19:0) (<italic>p</italic> = 9.39&#215;10<sup>&#8722;12</sup>, 38.8-fold elevated intensity in <italic>L</italic>. <italic>acidophilus</italic>). Furthermore, <italic>L</italic>. <italic>acidophilus</italic> appeared to exhibit a greater tendency to produce odd-chain lipids as 17 of the 19 odd-chain lipids detected were found to be elevated in <italic>L</italic>. <italic>acidophilus</italic>. Although the biological implications behind this observation are not immediately clear, it is known that Gram-positive bacteria can exhibit differential enzymatic biochemistry involved in lipid synthesis which can influencing the balance of even-versus-odd-chain fatty acid production [<xref ref-type="bibr" rid="pone.0222393.ref067">67</xref>]. Examining the general lipidomes of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>, we observed highly-differential class-level distribution of identified lipids as measured by summing the signal intensity of individual lipid classes (<xref ref-type="fig" rid="pone.0222393.g002">Fig 2</xref>). Both species displayed the same 5 lipid classes as the primary constituents (&gt;98%) of their lipidomes: DGs, DGDGs, PGs, bis(monoacylglycero)phosphates (BMPs), and cardiolipins (CLs). All other detected lipid classes comprised a minority of the total lipid signal (&#8804;2%) and are detailed in <xref ref-type="supplementary-material" rid="pone.0222393.s003">S2 Table</xref>. Although <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> were found to share the same 5 core lipid classes, the ratios of these classes as a measure of the total lipid signal are significantly different between species. In both <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>, DGs had the highest class representation at 41% and 59%, respectively. A difference of nearly 50% in the primary lipid class between two bacteria, especially within the same genus, is notable. In <italic>L</italic>. <italic>acidophilus</italic>, DGDGs represented 23% of the lipid signal, a sharp contrast to 5% in <italic>L</italic>. <italic>gasseri</italic>. PGs and BMPs were also very different between the species with PGs accounting for only 10% of the lipid signal in <italic>L</italic>. <italic>acidophilus</italic> and 25% in <italic>L</italic>. <italic>gasseri</italic>, and BMPs accounting for 17% of the lipid signal in <italic>L</italic>. <italic>acidophilus</italic> and 3% in <italic>L</italic>. <italic>gasseri</italic>. The only core lipid class that showed similar representation between species was CLs at 7% in <italic>L</italic>. <italic>acidophilus</italic> and 8% in <italic>L</italic>. <italic>gasseri</italic>. Gaining an understanding of the unique lipid profiles of these <italic>Lactobacillus</italic> species is important to understand their relationship with the host intestine. The composition of the cell structure directly affects how a bacterium responds to its environment, particularly through surface expression or secretion of key signaling and metabolic factors [<xref ref-type="bibr" rid="pone.0222393.ref068">68</xref>]. Certain <italic>Lactobacillus</italic> species have been shown to modify the composition of their lipid membranes as a protective mechanism against oxidative and thermal stress [<xref ref-type="bibr" rid="pone.0222393.ref069">69</xref>], salt exposure [<xref ref-type="bibr" rid="pone.0222393.ref070">70</xref>], and low pH [<xref ref-type="bibr" rid="pone.0222393.ref071">71</xref>]. Additionally, the nature of a bacterium&#8217;s surface lipid content allows for modulation of immune responses, specifically activation of the innate immune response, due to interaction between microbe-associated molecular patterns (including lipids) on the microbe surface and pattern recognition receptors on the mucosal surface, triggering production of a variety of effector molecules [<xref ref-type="bibr" rid="pone.0222393.ref072">72</xref>]. Hence, the lipid profiles of candidate probiotic bacteria should be considered a significant point of interest as some species, as a result of their unique lipid makeup, may exhibit more robust colonization and delivery of probiotic health benefits due to the extent at which they can adapt to environmental stressors and coexist within the host intestine. Further work is needed to confirm the biological functionality behind the differential expression observed in the <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> lipidomes.</p>
<fig id="pone.0222393.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0222393.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Distribution of identified lipid species by class intensity sum for <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>.</title>
<p>The majority of lipids were found to be diacylglycerols (DGs), digalactosyldiacylglycerols (DGDGs), phosphatidylglycerols (PGs), bis(monoacylglycero)phosphates (BMPs), and cardiolipins (CLs). Other detected lipid classes represented a minority (2% or less) of the total lipid signal. Significant variance in the relative ratios of these classes was observed between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>, with exception to CLs (7% and 8%, respectively), indicating the presence of species-specific lipid membrane compositions within <italic>Lactobacillus</italic>.</p>
</caption>
<graphic mimetype="image" position="float" ns0:href="info:doi/10.1371/journal.pone.0222393.g002" ns0:type="simple" />
</fig>
<table-wrap id="pone.0222393.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0222393.t002</object-id>
<label>Table 2</label> <caption><title>Top-25 identified lipids of greatest significant difference in signal intensity between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>.</title></caption>
<alternatives>
<graphic id="pone.0222393.t002g" mimetype="image" position="float" ns0:href="info:doi/10.1371/journal.pone.0222393.t002" ns0:type="simple" />
<table>
<colgroup>
<col align="left" valign="middle" />
<col align="left" valign="middle" />
<col align="left" valign="middle" />
<col align="left" valign="middle" />
<col align="left" valign="middle" />
<col align="left" valign="middle" />
<col align="left" valign="middle" />
<col align="left" valign="middle" />
</colgroup>
<thead>
<tr style="border-top:thick">
<th align="center">Lipid Species</th>
<th align="center">Exp Mass</th>
<th align="center" colspan="2">Ion</th>
<th align="center">Fold-Difference</th>
<th align="center">p-value</th>
<th align="center">Elevated Expression</th>
<th align="center">Additional Isomeric Identifications</th>
</tr>
</thead>
<tbody>
<tr style="border-top:thick">
<td align="center">DG(18:1/20:1)</td>
<td align="center">666.6038</td>
<td align="center">[M+NH4]+</td>
<td align="center">1</td>
<td align="center">697.5</td>
<td align="center">4.29E-12</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">DG(18:3/19:0)</td>
<td align="center">650.5719</td>
<td align="center">[M+NH4]+</td>
<td align="center">1</td>
<td align="center">15.1</td>
<td align="center">4.29E-12</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">DG(17:1/20:2) | DG(17:2/20:1)</td>
</tr>
<tr>
<td align="center">DG(18:2/19:0)</td>
<td align="center">652.5879</td>
<td align="center">[M+NH4]+</td>
<td align="center">1</td>
<td align="center">38.8</td>
<td align="center">9.39E-12</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">DGDG(18:2/19:0)</td>
<td align="center">976.6933</td>
<td align="center">[M+NH4]+</td>
<td align="center">1</td>
<td align="center">53.6</td>
<td align="center">4.84E-11</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">DGDG(37:2) | DGDG(17:2/20:0) | DGDG(17:1/20:1)</td>
</tr>
<tr>
<td align="center">DGDG(17:1/20:2)</td>
<td align="center">974.6768</td>
<td align="center">[M+NH4]+</td>
<td align="center">1</td>
<td align="center">78.8</td>
<td align="center">7.28E-11</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">DGDG(17:2/20:1) | DGDG(18:3/19:0) | DGDG(15:1/22:2) | DGDG(37:3)</td>
</tr>
<tr>
<td align="center">BMP(19:1/18:2)</td>
<td align="center">804.5748</td>
<td align="center">[M+NH4]+</td>
<td align="center">1</td>
<td align="center">4.9</td>
<td align="center">1.36E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">BMP(18:1/19:2) | PG(37:3)</td>
</tr>
<tr>
<td align="center">DG(17:0/18:1)</td>
<td align="center">626.5724</td>
<td align="center">[M+NH4]+</td>
<td align="center">1</td>
<td align="center">5.9</td>
<td align="center">1.36E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">PG(18:1/20:1)</td>
<td align="center">820.6067</td>
<td align="center">[M+NH4]+</td>
<td align="center">1,2</td>
<td align="center">50.9</td>
<td align="center">2.29E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">BMP(19:1/19:1) | PG(38:2) | | BMP(18:1/20:1)</td>
</tr>
<tr>
<td align="center">BMP(18:0/19:1)</td>
<td align="center">808.6065</td>
<td align="center">[M+NH4]+</td>
<td align="center">1</td>
<td align="center">7.1</td>
<td align="center">6.59E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">PG(37:1)</td>
</tr>
<tr>
<td align="center">HexCer-NS(d18:1/22:1)</td>
<td align="center">782.6506</td>
<td align="center">[M+H]+</td>
<td align="center">2</td>
<td align="center">1.7</td>
<td align="center">6.59E-10</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">DGDG(17:0/18:1)</td>
<td align="center">950.6786</td>
<td align="center">[M+NH4]+</td>
<td align="center">1</td>
<td align="center">5.3</td>
<td align="center">3.92E-09</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">DGDG(35:1)</td>
</tr>
<tr style="border-bottom:thick">
<td align="center">DGDG(18:1/19:0)</td>
<td align="center">978.7096</td>
<td align="center">[M+NH4]+</td>
<td align="center">1</td>
<td align="center">78.7</td>
<td align="center">5.22E-09</td>
<td align="center"><italic>L</italic>. <italic>acidophilus</italic></td>
<td align="center">DGDG(37:1)</td>
</tr>
<tr>
<td align="center">DGDG(18:1/18:1)</td>
<td align="center">989.6444</td>
<td align="center">[M+HCO2]-</td>
<td align="center">1</td>
<td align="center">10.5</td>
<td align="center">4.35E-12</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">PG(18:1/18:1)</td>
<td align="center">773.5359</td>
<td align="center">[M-H]-</td>
<td align="center">1,2</td>
<td align="center">6.4</td>
<td align="center">1.45E-11</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">PG(18:0/18:2)</td>
</tr>
<tr>
<td align="center">PG(18:1/18:2)</td>
<td align="center">771.5200</td>
<td align="center">[M-H]-</td>
<td align="center">1,2</td>
<td align="center">6.0</td>
<td align="center">1.63E-11</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">PG(18:0/18:1)</td>
<td align="center">775.5512</td>
<td align="center">[M-H]-</td>
<td align="center">1,2</td>
<td align="center">4.1</td>
<td align="center">2.52E-11</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">DGDG(18:1/18:2)</td>
<td align="center">987.6286</td>
<td align="center">[M+HCO2]-</td>
<td align="center">1</td>
<td align="center">3.9</td>
<td align="center">5.35E-11</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">PG(18:1/18:3)</td>
<td align="center">769.5049</td>
<td align="center">[M-H]-</td>
<td align="center">1,2</td>
<td align="center">6.6</td>
<td align="center">5.84E-11</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">PG(18:2/18:2)</td>
</tr>
<tr>
<td align="center">DGDG(16:0/18:1)</td>
<td align="center">963.6285</td>
<td align="center">[M+HCO2]-</td>
<td align="center">1</td>
<td align="center">5.1</td>
<td align="center">9.60E-11</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">PG(8:0/18:1)</td>
<td align="center">635.3940</td>
<td align="center">[M-H]-</td>
<td align="center">1</td>
<td align="center">6.9</td>
<td align="center">6.26E-10</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">CL(36:2)(36:2)</td>
<td align="center">1475.0696</td>
<td align="center">[M+NH4]+</td>
<td align="center">1,2</td>
<td align="center">30.0</td>
<td align="center">1.13E-09</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">CL(36:1)(36:3)</td>
</tr>
<tr>
<td align="center">PG(12:0/18:1)</td>
<td align="center">691.4572</td>
<td align="center">[M-H]-</td>
<td align="center">1</td>
<td align="center">3.5</td>
<td align="center">1.90E-09</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">HexCer-NS(d18:1/18:1)</td>
<td align="center">726.5886</td>
<td align="center">[M+H]+</td>
<td align="center">2</td>
<td align="center">50.3</td>
<td align="center">2.76E-09</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">&#160;</td>
</tr>
<tr>
<td align="center">PG(16:1/18:1)</td>
<td align="center">745.5043</td>
<td align="center">[M-H]-</td>
<td align="center">1</td>
<td align="center">6.7</td>
<td align="center">5.28E-09</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">PG(16:0/18:2)</td>
</tr>
<tr style="border-bottom:thick">
<td align="center">CL(18:1/18:1/18:1/18:1)</td>
<td align="center">727.5119</td>
<td align="center">[M-2H]2-</td>
<td align="center">1,2</td>
<td align="center">4.2</td>
<td align="center">7.17E-09</td>
<td align="center"><italic>L</italic>. <italic>gasseri</italic></td>
<td align="center">&#160;</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>Detection: 1 = Data-Dependent (top 5) MS/MS fragment <italic>m/z</italic> match, 2 = All-Ion-Fragmentation MS/MS fragment <italic>m/z</italic> match</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec013">
<title>Oxalate degradation by <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic></title>
<p>Liquid scintillation counting evaluation of oxalate degradation by <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> demonstrated significant degradation by both species. <italic>L</italic>. <italic>acidophilus</italic> showed 100% degradation of the <sup>14</sup>C-oxalate with ~ 44% of counts remaining representing <sup>14</sup>C-formate in the media from enzymatic <sup>14</sup>C-oxalate degradation via oxalate decarboxylase [<xref ref-type="bibr" rid="pone.0222393.ref073">73</xref>]. <italic>L</italic>. <italic>gasseri</italic> showed ~ 72% of counts remaining, meaning it degraded ~50% of the <sup>14</sup>C-oxalate in the media. Our findings are consistent with past experiments reporting oxalate degradation by both <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> in the presence of other carbon sources with <italic>L</italic>. <italic>acidophilus</italic> being noted as a more efficient degrader [<xref ref-type="bibr" rid="pone.0222393.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0222393.ref016">16</xref>]. These results provide further evidence supporting the evaluation of these <italic>Lactobacillus</italic> species as potential probiotic remedies for oxalate pathologies.</p>
</sec>
</sec>
<sec id="sec014" sec-type="conclusions">
<title>Conclusions</title>
<p>We conclude that the metabolomes and lipidomes of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> displayed appreciable differentiation both in terms of their general profiles and relative expression of individual compounds. Although we successfully identified 97 metabolites and 71 lipids between these species, we acknowledge that there are many factors yet to be characterized in the <italic>Lactobacillus</italic> metabolic pool. Among the metabolites we identified, several hold potential to provide immune support and other benefits to the host in a probiotic relationship. We tested and verified the ability of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> to degrade oxalate even with availability of other carbon sources, providing supporting evidence for the need to further evaluate these <italic>Lactobacillus</italic> species as probiotic treatments for oxalate conditions. Further work is needed to fully define and characterize the <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic> metabolic profiles and validate their performance as oxalate-targeting probiotics.</p>
</sec>
<sec id="sec015">
<title>Supporting information</title>
<supplementary-material id="pone.0222393.s001" mimetype="image/tiff" position="float" ns0:href="info:doi/10.1371/journal.pone.0222393.s001" ns0:type="simple">
<label>S1 Fig</label>
<caption>
<title>Principal component analysis scores plots for the metabolomic and lipidomic comparisons of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>.</title>
<p>PCA depicts clear separation and analytical distinction between the global metabolomes (A) and lipidomes (B) of <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>. In the metabolomics analysis, 76.8% of the variance is explained in 2 PCs, mostly accounted for by PC1, and 89.0% explained in 5 PCs. In the lipidomics analysis 83.7% of the variance is explained in 2 PCs, mostly accounted for by PC1, and 94.0% explained in 5 PCs.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0222393.s002" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" ns0:href="info:doi/10.1371/journal.pone.0222393.s002" ns0:type="simple">
<label>S1 Table</label>
<caption>
<title>All 97 identified metabolites (<italic>m/z</italic> &amp; retention time match to analytical standard) with significance and magnitude of signal intensity difference between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>.</title>
<p>Significance: p&#8804;1E-03.</p>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0222393.s003" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" ns0:href="info:doi/10.1371/journal.pone.0222393.s003" ns0:type="simple">
<label>S2 Table</label>
<caption>
<title>All 71 identified lipids with significance and magnitude of signal intensity difference between <italic>L</italic>. <italic>acidophilus</italic> and <italic>L</italic>. <italic>gasseri</italic>.</title>
<p>Detection: 1 = Data-Dependent (top 5) MS/MS fragment <italic>m/z</italic> match, 2 = All-Ion-Fragmentation MS/MS fragment <italic>m/z</italic> match, 3 = Headgroup <italic>m/z</italic> match (class-ID). Significance: p&#8804;1E-03.</p>
<p>(XLSX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>This work was funded by the National Institutes of Health (Grant # 2R01DK088892-05A1). The authors would like to acknowledge Dr. Cory A. Leonard, University of Florida Department of Pathology, Immunology and Laboratory Medicine, for her assistance with sample generation, including media preparation and cell culture, harvest, and lysis. Also to be acknowledged are Dr. Jeremy P. Koelmel, Yale University Environmental Health Sciences Department, for his assistance with the lipidomics analysis, and Vanessa Y. Rubio, University of Florida Department of Chemistry, for her contribution to the graphical abstract. Data from this study is available at <ext-link ext-link-type="uri" ns0:href="http://www.metabolomicsworkbench.org/" ns0:type="simple">www.metabolomicsworkbench.org</ext-link> (data track ID 1809).</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>BMP</term>
<def><p>Bis(monoacylglycero)Phosphate</p></def>
</def-item>
<def-item><term>CER</term>
<def><p>Ceramide</p></def>
</def-item>
<def-item><term>CL</term>
<def><p>Cardiolipin</p></def>
</def-item>
<def-item><term>DG</term>
<def><p>Diacylglyercol</p></def>
</def-item>
<def-item><term>DGDG</term>
<def><p>Digalactosyldiacylglycerol</p></def>
</def-item>
<def-item><term>HBMP</term>
<def><p>Hemibismonoacylglycerophosphate</p></def>
</def-item>
<def-item><term>HexCer-NS</term>
<def><p>Hexosylceramide Non-Hydroxy Fatty Acid-Sphingosine</p></def>
</def-item>
<def-item><term>LPC</term>
<def><p>Lyosphosphatidylcholine</p></def>
</def-item>
<def-item><term>LSM</term>
<def><p>Lysosphinomyelin</p></def>
</def-item>
<def-item><term>MGDG</term>
<def><p>Monogalactosyldiacylglycerol</p></def>
</def-item>
<def-item><term>OxPG</term>
<def><p>Oxidized Phosphatidylglycerol</p></def>
</def-item>
<def-item><term>PA</term>
<def><p>Phosphatidic Acid</p></def>
</def-item>
<def-item><term>PAzePC</term>
<def><p>Oxidized Phosphatidylethanolamine 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine</p></def>
</def-item>
<def-item><term>PC</term>
<def><p>Phosphatidylcholine</p></def>
</def-item>
<def-item><term>PE</term>
<def><p>Phosphatidylethanolamine</p></def>
</def-item>
<def-item><term>PG</term>
<def><p>Phosphatidylglycerol</p></def>
</def-item>
<def-item><term>PI</term>
<def><p>Phosphatidylinositol</p></def>
</def-item>
<def-item><term>PS</term>
<def><p>Phosphatidylserine</p></def>
</def-item>
<def-item><term>SO</term>
<def><p>Sphingosine</p></def>
</def-item>
<def-item><term>TG</term>
<def><p>Triacylglycerol</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pone.0222393.ref001"><label>1</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Fijan</surname> <given-names>S.</given-names></name> <article-title>Microorganisms with claimed probiotic properties: an overview of recent literature</article-title>. <source>Int J Environ Res Public Health</source>. <year>2014</year>;<volume>11</volume>(<issue>5</issue>):<fpage>4745</fpage>&#8211;<lpage>67</lpage>. Epub 2014/05/05. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.3390/ijerph110504745" ns0:type="simple">10.3390/ijerph110504745</ext-link></comment> <object-id pub-id-type="pmid">24859749</object-id>; PubMed Central PMCID: PMC4053917.</mixed-citation></ref>
<ref id="pone.0222393.ref002"><label>2</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Hill</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Guarner</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Reid</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gibson</surname> <given-names>GR</given-names></name>, <name name-style="western"><surname>Merenstein</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Pot</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. <year>2014</year>;<volume>11</volume>(<issue>8</issue>):<fpage>506</fpage>&#8211;<lpage>14</lpage>. Epub 2014/06/10. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1038/nrgastro.2014.66" ns0:type="simple">10.1038/nrgastro.2014.66</ext-link></comment> <object-id pub-id-type="pmid">24912386</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref003"><label>3</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Venugopalan</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Shriner</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Wong-Beringer</surname> <given-names>A</given-names></name>. <article-title>Regulatory oversight and safety of probiotic use</article-title>. <source>Emerg Infect Dis</source>. <year>2010</year>;<volume>16</volume>(<issue>11</issue>):<fpage>1661</fpage>&#8211;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.3201/eid1611.100574" ns0:type="simple">10.3201/eid1611.100574</ext-link></comment> <object-id pub-id-type="pmid">21029521</object-id>; PubMed Central PMCID: PMC3294522.</mixed-citation></ref>
<ref id="pone.0222393.ref004"><label>4</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>La Fata</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Weber</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mohajeri</surname> <given-names>MH</given-names></name>. <article-title>Probiotics and the Gut Immune System: Indirect Regulation</article-title>. <source>Probiotics Antimicrob Proteins</source>. <year>2018</year>;<volume>10</volume>(<issue>1</issue>):<fpage>11</fpage>&#8211;<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1007/s12602-017-9322-6" ns0:type="simple">10.1007/s12602-017-9322-6</ext-link></comment> PubMed Central PMCID: PMC5801397. <object-id pub-id-type="pmid">28861741</object-id></mixed-citation></ref>
<ref id="pone.0222393.ref005"><label>5</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Dimidi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Christodoulides</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Scott</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Whelan</surname> <given-names>K</given-names></name>. <article-title>Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation</article-title>. <source>Adv Nutr</source>. <year>2017</year>;<volume>8</volume>(<issue>3</issue>):<fpage>484</fpage>&#8211;<lpage>94</lpage>. Epub 2017/05/15. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.3945/an.116.014407" ns0:type="simple">10.3945/an.116.014407</ext-link></comment> <object-id pub-id-type="pmid">28507013</object-id>; PubMed Central PMCID: PMC5421123.</mixed-citation></ref>
<ref id="pone.0222393.ref006"><label>6</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Ettinger</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>MacDonald</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Reid</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Burton</surname> <given-names>JP</given-names></name>. <article-title>The influence of the human microbiome and probiotics on cardiovascular health</article-title>. <source>Gut Microbes</source>. <year>2014</year>;<volume>5</volume>(<issue>6</issue>):<fpage>719</fpage>&#8211;<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.4161/19490976.2014.983775" ns0:type="simple">10.4161/19490976.2014.983775</ext-link></comment> <object-id pub-id-type="pmid">25529048</object-id>; PubMed Central PMCID: PMC4615746.</mixed-citation></ref>
<ref id="pone.0222393.ref007"><label>7</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Di Felice</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Barletta</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Butteroni</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Corinti</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tinghino</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Colombo</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Use of probiotic bacteria for prevention and therapy of allergic diseases: studies in mouse model of allergic sensitization</article-title>. <source>J Clin Gastroenterol</source>. <year>2008</year>;<volume>42</volume> <issue>Suppl 3</issue> Pt 1:<fpage>S130</fpage>&#8211;<lpage>2</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1097/MCG.0b013e318169c463" ns0:type="simple">10.1097/MCG.0b013e318169c463</ext-link></comment> <object-id pub-id-type="pmid">18806704</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref008"><label>8</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Pirbaglou</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Katz</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>de Souza</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Stearns</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Motamed</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ritvo</surname> <given-names>P</given-names></name>. <article-title>Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials</article-title>. <source>Nutr Res</source>. <year>2016</year>;<volume>36</volume>(<issue>9</issue>):<fpage>889</fpage>&#8211;<lpage>98</lpage>. Epub 2016/06/21. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/j.nutres.2016.06.009" ns0:type="simple">10.1016/j.nutres.2016.06.009</ext-link></comment> <object-id pub-id-type="pmid">27632908</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref009"><label>9</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Behnsen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Deriu</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Sassone-Corsi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Raffatellu</surname> <given-names>M</given-names></name>. <article-title>Probiotics: properties, examples, and specific applications</article-title>. <source>Cold Spring Harb Perspect Med</source>. <year>2013</year>;<volume>3</volume>(<issue>3</issue>):<fpage>a010074</fpage>. Epub 2013/03/01. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1101/cshperspect.a010074" ns0:type="simple">10.1101/cshperspect.a010074</ext-link></comment> <object-id pub-id-type="pmid">23457295</object-id>; PubMed Central PMCID: PMC3579206.</mixed-citation></ref>
<ref id="pone.0222393.ref010"><label>10</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Heeney</surname> <given-names>DD</given-names></name>, <name name-style="western"><surname>Gareau</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Marco</surname> <given-names>ML</given-names></name>. <article-title>Intestinal Lactobacillus in health and disease, a driver or just along for the ride</article-title>? <source>Curr Opin Biotechnol</source>. <year>2018</year>;<volume>49</volume>:<fpage>140</fpage>&#8211;<lpage>7</lpage>. Epub 2017/09/01. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/j.copbio.2017.08.004" ns0:type="simple">10.1016/j.copbio.2017.08.004</ext-link></comment> <object-id pub-id-type="pmid">28866243</object-id>; PubMed Central PMCID: PMC5808898.</mixed-citation></ref>
<ref id="pone.0222393.ref011"><label>11</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Rossi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mart&#237;nez-Mart&#237;nez</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Amaretti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ulrici</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Raimondi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Moya</surname> <given-names>A</given-names></name>. <article-title>Mining metagenomic whole genome sequences revealed subdominant but constant Lactobacillus population in the human gut microbiota</article-title>. <source>Environ Microbiol</source>. <year>2016</year>. Epub 2016/03/11. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1111/1462-2920.13295" ns0:type="simple">10.1111/1462-2920.13295</ext-link></comment> <object-id pub-id-type="pmid">26970435</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref012"><label>12</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Walter</surname> <given-names>J.</given-names></name> <article-title>Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research</article-title>. <source>Appl Environ Microbiol</source>. <year>2008</year>;<volume>74</volume>(<issue>16</issue>):<fpage>4985</fpage>&#8211;<lpage>96</lpage>. Epub 2008/06/06. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1128/AEM.00753-08" ns0:type="simple">10.1128/AEM.00753-08</ext-link></comment> <object-id pub-id-type="pmid">18539818</object-id>; PubMed Central PMCID: PMC2519286.</mixed-citation></ref>
<ref id="pone.0222393.ref013"><label>13</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Frank</surname> <given-names>DN</given-names></name>, <name name-style="western"><surname>Pace</surname> <given-names>NR</given-names></name>. <article-title>Gastrointestinal microbiology enters the metagenomics era</article-title>. <source>Curr Opin Gastroenterol</source>. <year>2008</year>;<volume>24</volume>(<issue>1</issue>):<fpage>4</fpage>&#8211;<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1097/MOG.0b013e3282f2b0e8" ns0:type="simple">10.1097/MOG.0b013e3282f2b0e8</ext-link></comment> <object-id pub-id-type="pmid">18043225</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref014"><label>14</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>McFarland</surname> <given-names>LV</given-names></name>, <name name-style="western"><surname>Evans</surname> <given-names>CT</given-names></name>, <name name-style="western"><surname>Goldstein</surname> <given-names>EJC</given-names></name>. <article-title>Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis</article-title>. <source>Front Med (Lausanne)</source>. <year>2018</year>;<volume>5</volume>:<fpage>124</fpage>. Epub 2018/05/07. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.3389/fmed.2018.00124" ns0:type="simple">10.3389/fmed.2018.00124</ext-link></comment> <object-id pub-id-type="pmid">29868585</object-id>; PubMed Central PMCID: PMC5949321.</mixed-citation></ref>
<ref id="pone.0222393.ref015"><label>15</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Turroni</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Vitali</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Bendazzoli</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Candela</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gotti</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Federici</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus</article-title>. <source>J Appl Microbiol</source>. <year>2007</year>;<volume>103</volume>(<issue>5</issue>):<fpage>1600</fpage>&#8211;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1111/j.1365-2672.2007.03388.x" ns0:type="simple">10.1111/j.1365-2672.2007.03388.x</ext-link></comment> <object-id pub-id-type="pmid">17953571</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref016"><label>16</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Hatch</surname> <given-names>M.</given-names></name> <article-title>Gut microbiota and oxalate homeostasis</article-title>. <source>Ann Transl Med</source>. <year>2017</year>;<volume>5</volume>(<issue>2</issue>):<fpage>36</fpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.21037/atm.2016.12.70" ns0:type="simple">10.21037/atm.2016.12.70</ext-link></comment> <object-id pub-id-type="pmid">28217701</object-id>; PubMed Central PMCID: PMC5300851.</mixed-citation></ref>
<ref id="pone.0222393.ref017"><label>17</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Holmes</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Goodman</surname> <given-names>HO</given-names></name>, <name name-style="western"><surname>Assimos</surname> <given-names>DG</given-names></name>. <article-title>Contribution of dietary oxalate to urinary oxalate excretion</article-title>. <source>Kidney Int</source>. <year>2001</year>;<volume>59</volume>(<issue>1</issue>):<fpage>270</fpage>&#8211;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1046/j.1523-1755.2001.00488.x" ns0:type="simple">10.1046/j.1523-1755.2001.00488.x</ext-link></comment> <object-id pub-id-type="pmid">11135080</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref018"><label>18</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Holmes</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Assimos</surname> <given-names>DG</given-names></name>. <article-title>Glyoxylate synthesis, and its modulation and influence on oxalate synthesis</article-title>. <source>J Urol</source>. <year>1998</year>;<volume>160</volume>(<issue>5</issue>):<fpage>1617</fpage>&#8211;<lpage>24</lpage>. <object-id pub-id-type="pmid">9783918</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref019"><label>19</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Miller</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Dearing</surname> <given-names>D</given-names></name>. <article-title>The metabolic and ecological interactions of oxalate-degrading bacteria in the Mammalian gut</article-title>. <source>Pathogens</source>. <year>2013</year>;<volume>2</volume>(<issue>4</issue>):<fpage>636</fpage>&#8211;<lpage>52</lpage>. Epub 2013/12/06. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.3390/pathogens2040636" ns0:type="simple">10.3390/pathogens2040636</ext-link></comment> <object-id pub-id-type="pmid">25437337</object-id>; PubMed Central PMCID: PMC4235702.</mixed-citation></ref>
<ref id="pone.0222393.ref020"><label>20</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Worcester</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Coe</surname> <given-names>FL</given-names></name>. <article-title>Nephrolithiasis</article-title>. <source>Prim Care</source>. <year>2008</year>;<volume>35</volume>(<issue>2</issue>):<fpage>369</fpage>&#8211;91, <lpage>vii</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/j.pop.2008.01.005" ns0:type="simple">10.1016/j.pop.2008.01.005</ext-link></comment> <object-id pub-id-type="pmid">18486720</object-id>; PubMed Central PMCID: PMC2518455.</mixed-citation></ref>
<ref id="pone.0222393.ref021"><label>21</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Khan</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Pearle</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Robertson</surname> <given-names>WG</given-names></name>, <name name-style="western"><surname>Gambaro</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Canales</surname> <given-names>BK</given-names></name>, <name name-style="western"><surname>Doizi</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Kidney stones</article-title>. <source>Nat Rev Dis Primers</source>. <year>2017</year>;<volume>3</volume>:<fpage>17001</fpage>. Epub 2017/01/12. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1038/nrdp.2017.1" ns0:type="simple">10.1038/nrdp.2017.1</ext-link></comment> <object-id pub-id-type="pmid">28079115</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref022"><label>22</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Abratt</surname> <given-names>VR</given-names></name>, <name name-style="western"><surname>Reid</surname> <given-names>SJ</given-names></name>. <article-title>Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease</article-title>. <source>Adv Appl Microbiol</source>. <year>2010</year>;<volume>72</volume>:<fpage>63</fpage>&#8211;<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/S0065-2164(10)72003-7" ns0:type="simple">10.1016/S0065-2164(10)72003-7</ext-link></comment> <object-id pub-id-type="pmid">20602988</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref023"><label>23</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Liebman</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Al-Wahsh</surname> <given-names>IA</given-names></name>. <article-title>Probiotics and other key determinants of dietary oxalate absorption</article-title>. <source>Adv Nutr</source>. <year>2011</year>;<volume>2</volume>(<issue>3</issue>):<fpage>254</fpage>&#8211;<lpage>60</lpage>. Epub 2011/04/30. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.3945/an.111.000414" ns0:type="simple">10.3945/an.111.000414</ext-link></comment> <object-id pub-id-type="pmid">22332057</object-id>; PubMed Central PMCID: PMC3090165.</mixed-citation></ref>
<ref id="pone.0222393.ref024"><label>24</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Hatch</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Freel</surname> <given-names>RW</given-names></name>. <article-title>The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis</article-title>. <source>Semin Nephrol</source>. <year>2008</year>;<volume>28</volume>(<issue>2</issue>):<fpage>143</fpage>&#8211;<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/j.semnephrol.2008.01.007" ns0:type="simple">10.1016/j.semnephrol.2008.01.007</ext-link></comment> <object-id pub-id-type="pmid">18359395</object-id>; PubMed Central PMCID: PMC2430047.</mixed-citation></ref>
<ref id="pone.0222393.ref025"><label>25</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Whittamore</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Hatch</surname> <given-names>M</given-names></name>. <article-title>The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man</article-title>. <source>Urolithiasis</source>. <year>2017</year>;<volume>45</volume>(<issue>1</issue>):<fpage>89</fpage>&#8211;<lpage>108</lpage>. Epub 2016/12/02. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1007/s00240-016-0952-z" ns0:type="simple">10.1007/s00240-016-0952-z</ext-link></comment> <object-id pub-id-type="pmid">27913853</object-id>; PubMed Central PMCID: PMC5358548.</mixed-citation></ref>
<ref id="pone.0222393.ref026"><label>26</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Selle</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Klaenhammer</surname> <given-names>TR</given-names></name>. <article-title>Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health</article-title>. <source>FEMS Microbiol Rev</source>. <year>2013</year>;<volume>37</volume>(<issue>6</issue>):<fpage>915</fpage>&#8211;<lpage>35</lpage>. Epub 2013/04/12. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1111/1574-6976.12021" ns0:type="simple">10.1111/1574-6976.12021</ext-link></comment> <object-id pub-id-type="pmid">23488471</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref027"><label>27</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Cho</surname> <given-names>YA</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>J</given-names></name>. <article-title>Effect of Probiotics on Blood Lipid Concentrations: A Meta-Analysis of Randomized Controlled Trials</article-title>. <source>Medicine (Baltimore)</source>. <year>2015</year>;<volume>94</volume>(<issue>43</issue>):<fpage>e1714</fpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1097/MD.0000000000001714" ns0:type="simple">10.1097/MD.0000000000001714</ext-link></comment> <object-id pub-id-type="pmid">26512560</object-id>; PubMed Central PMCID: PMC4985374.</mixed-citation></ref>
<ref id="pone.0222393.ref028"><label>28</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Shimizu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hashiguchi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shiga</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Tamura</surname> <given-names>HO</given-names></name>, <name name-style="western"><surname>Mochizuki</surname> <given-names>M</given-names></name>. <article-title>Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic Individuals</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>10</issue>):<fpage>e0139795</fpage>. Epub 2015/10/16. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1371/journal.pone.0139795" ns0:type="simple">10.1371/journal.pone.0139795</ext-link></comment> <object-id pub-id-type="pmid">26473340</object-id>; PubMed Central PMCID: PMC4608827.</mixed-citation></ref>
<ref id="pone.0222393.ref029"><label>29</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Sazawal</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hiremath</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Dhingra</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Malik</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Deb</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Black</surname> <given-names>RE</given-names></name>. <article-title>Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials</article-title>. <source>Lancet Infect Dis</source>. <year>2006</year>;<volume>6</volume>(<issue>6</issue>):<fpage>374</fpage>&#8211;<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/S1473-3099(06)70495-9" ns0:type="simple">10.1016/S1473-3099(06)70495-9</ext-link></comment> <object-id pub-id-type="pmid">16728323</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref030"><label>30</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Gao</surname> <given-names>XW</given-names></name>, <name name-style="western"><surname>Mubasher</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fang</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Reifer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>LE</given-names></name>. <article-title>Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients</article-title>. <source>Am J Gastroenterol</source>. <year>2010</year>;<volume>105</volume>(<issue>7</issue>):<fpage>1636</fpage>&#8211;<lpage>41</lpage>. Epub 2010/02/09. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1038/ajg.2010.11" ns0:type="simple">10.1038/ajg.2010.11</ext-link></comment> <object-id pub-id-type="pmid">20145608</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref031"><label>31</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Ringel-Kulka</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Palsson</surname> <given-names>OS</given-names></name>, <name name-style="western"><surname>Maier</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Carroll</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Galanko</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Leyer</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study</article-title>. <source>J Clin Gastroenterol</source>. <year>2011</year>;<volume>45</volume>(<issue>6</issue>):<fpage>518</fpage>&#8211;<lpage>25</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1097/MCG.0b013e31820ca4d6" ns0:type="simple">10.1097/MCG.0b013e31820ca4d6</ext-link></comment> <object-id pub-id-type="pmid">21436726</object-id>; PubMed Central PMCID: PMC4372813.</mixed-citation></ref>
<ref id="pone.0222393.ref032"><label>32</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Sinn</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Son</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>DK</given-names></name>, <etal>et al</etal>. <article-title>Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome</article-title>. <source>Dig Dis Sci</source>. <year>2008</year>;<volume>53</volume>(<issue>10</issue>):<fpage>2714</fpage>&#8211;<lpage>8</lpage>. Epub 2008/02/15. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1007/s10620-007-0196-4" ns0:type="simple">10.1007/s10620-007-0196-4</ext-link></comment> <object-id pub-id-type="pmid">18274900</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref033"><label>33</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Ya</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Reifer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>LE</given-names></name>. <article-title>Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study</article-title>. <source>Am J Obstet Gynecol</source>. <year>2010</year>;<volume>203</volume>(<issue>2</issue>):<fpage>120.e1</fpage>&#8211;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/j.ajog.2010.05.023" ns0:type="simple">10.1016/j.ajog.2010.05.023</ext-link></comment> <object-id pub-id-type="pmid">20659602</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref034"><label>34</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Ouwehand</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Nermes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Collado</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Rautonen</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Salminen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Isolauri</surname> <given-names>E</given-names></name>. <article-title>Specific probiotics alleviate allergic rhinitis during the birch pollen season</article-title>. <source>World J Gastroenterol</source>. <year>2009</year>;<volume>15</volume>(<issue>26</issue>):<fpage>3261</fpage>&#8211;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.3748/wjg.15.3261" ns0:type="simple">10.3748/wjg.15.3261</ext-link></comment> <object-id pub-id-type="pmid">19598302</object-id>; PubMed Central PMCID: PMC2710782.</mixed-citation></ref>
<ref id="pone.0222393.ref035"><label>35</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>van Baarlen</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Troost</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>van der Meer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hooiveld</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Boekschoten</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Brummer</surname> <given-names>RJ</given-names></name>, <etal>et al</etal>. <article-title>Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume> <issue>Suppl 1</issue>:<fpage>4562</fpage>&#8211;<lpage>9</lpage>. Epub 2010/09/07. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1073/pnas.1000079107" ns0:type="simple">10.1073/pnas.1000079107</ext-link></comment> <object-id pub-id-type="pmid">20823239</object-id>; PubMed Central PMCID: PMC3063594.</mixed-citation></ref>
<ref id="pone.0222393.ref036"><label>36</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Ferrarese</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ceresola</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>Preti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Canducci</surname> <given-names>F</given-names></name>. <article-title>Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era</article-title>. <source>Eur Rev Med Pharmacol Sci</source>. <year>2018</year>;<volume>22</volume>(<issue>21</issue>):<fpage>7588</fpage>&#8211;<lpage>605</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.26355/eurrev_201811_16301" ns0:type="simple">10.26355/eurrev_201811_16301</ext-link></comment> <object-id pub-id-type="pmid">30468509</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref037"><label>37</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Yun</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Kwon</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Cho</surname> <given-names>B</given-names></name>. <article-title>Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial</article-title>. <source>J Med Food</source>. <year>2018</year>;<volume>21</volume>(<issue>5</issue>):<fpage>454</fpage>&#8211;<lpage>61</lpage>. Epub 2018/04/24. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1089/jmf.2017.3937" ns0:type="simple">10.1089/jmf.2017.3937</ext-link></comment> <object-id pub-id-type="pmid">29688793</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref038"><label>38</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Chamberlain</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Hatch</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Garrett</surname> <given-names>TJ</given-names></name>. <article-title>Metabolomic and lipidomic characterization of Oxalobacter formigenes strains HC1 and OxWR by UHPLC-HRMS</article-title>. <source>Anal Bioanal Chem</source>. <year>2019</year>. Epub 2019/02/11. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1007/s00216-019-01639-y" ns0:type="simple">10.1007/s00216-019-01639-y</ext-link></comment> <object-id pub-id-type="pmid">30740635</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref039"><label>39</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Chamberlain</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Rubio</surname> <given-names>VY</given-names></name>, <name name-style="western"><surname>Garrett</surname> <given-names>TJ</given-names></name>. <article-title>Strain-Level Differentiation of Bacteria by Paper Spray Ionization Mass Spectrometry</article-title>. <source>Analytical chemistry</source>. <year>2019</year>;<volume>91</volume>(<issue>8</issue>):<fpage>4964</fpage>&#8211;<lpage>8</lpage>. Epub 2019/03/20. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1021/acs.analchem.9b00330" ns0:type="simple">10.1021/acs.analchem.9b00330</ext-link></comment> <object-id pub-id-type="pmid">30888152</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref040"><label>40</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Hatch</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cornelius</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Allison</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sidhu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Peck</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Freel</surname> <given-names>RW</given-names></name>. <article-title>Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion</article-title>. <source>Kidney Int</source>. <year>2006</year>;<volume>69</volume>(<issue>4</issue>):<fpage>691</fpage>&#8211;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1038/sj.ki.5000162" ns0:type="simple">10.1038/sj.ki.5000162</ext-link></comment> <object-id pub-id-type="pmid">16518326</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref041"><label>41</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>FOLCH</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>LEES</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>SLOANE STANLEY</surname> <given-names>GH</given-names></name>. <article-title>A simple method for the isolation and purification of total lipides from animal tissues</article-title>. <source>J Biol Chem</source>. <year>1957</year>;<volume>226</volume>(<issue>1</issue>):<fpage>497</fpage>&#8211;<lpage>509</lpage>. <object-id pub-id-type="pmid">13428781</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref042"><label>42</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Koelmel</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Kroeger</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Gill</surname> <given-names>EL</given-names></name>, <name name-style="western"><surname>Ulmer</surname> <given-names>CZ</given-names></name>, <name name-style="western"><surname>Bowden</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Patterson</surname> <given-names>RE</given-names></name>, <etal>et al</etal>. <article-title>Expanding Lipidome Coverage Using LC-MS/MS Data-Dependent Acquisition with Automated Exclusion List Generation</article-title>. <source>J Am Soc Mass Spectrom</source>. <year>2017</year>;<volume>28</volume>(<issue>5</issue>):<fpage>908</fpage>&#8211;<lpage>17</lpage>. Epub 2017/03/06. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1007/s13361-017-1608-0" ns0:type="simple">10.1007/s13361-017-1608-0</ext-link></comment> <object-id pub-id-type="pmid">28265968</object-id>; PubMed Central PMCID: PMC5408749.</mixed-citation></ref>
<ref id="pone.0222393.ref043"><label>43</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>He</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Diedrich</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chu</surname> <given-names>YY</given-names></name>, <name name-style="western"><surname>Yates</surname> <given-names>JR</given-names></name>. <article-title>Extracting Accurate Precursor Information for Tandem Mass Spectra by RawConverter</article-title>. <source>Anal Chem</source>. <year>2015</year>;<volume>87</volume>(<issue>22</issue>):<fpage>11361</fpage>&#8211;<lpage>7</lpage>. Epub 2015/11/04. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1021/acs.analchem.5b02721" ns0:type="simple">10.1021/acs.analchem.5b02721</ext-link></comment> <object-id pub-id-type="pmid">26499134</object-id>; PubMed Central PMCID: PMC4777630.</mixed-citation></ref>
<ref id="pone.0222393.ref044"><label>44</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Pluskal</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Castillo</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Villar-Briones</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Oresic</surname> <given-names>M</given-names></name>. <article-title>MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data</article-title>. <source>BMC Bioinformatics</source>. <year>2010</year>;<volume>11</volume>:<fpage>395</fpage>. Epub 2010/07/23. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1186/1471-2105-11-395" ns0:type="simple">10.1186/1471-2105-11-395</ext-link></comment> <object-id pub-id-type="pmid">20650010</object-id>; PubMed Central PMCID: PMC2918584.</mixed-citation></ref>
<ref id="pone.0222393.ref045"><label>45</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Wehrens</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hageman</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>van Eeuwijk</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Kooke</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Flood</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Wijnker</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Improved batch correction in untargeted MS-based metabolomics</article-title>. <source>Metabolomics</source>. <year>2016</year>;<volume>12</volume>:<fpage>88</fpage>. Epub 2016/03/18. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1007/s11306-016-1015-8" ns0:type="simple">10.1007/s11306-016-1015-8</ext-link></comment> <object-id pub-id-type="pmid">27073351</object-id>; <source>PubMed Central PMCID</source>: PMC4796354.</mixed-citation></ref>
<ref id="pone.0222393.ref046"><label>46</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Koelmel</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Kroeger</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Ulmer</surname> <given-names>CZ</given-names></name>, <name name-style="western"><surname>Bowden</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Patterson</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Cochran</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>LipidMatch: an automated workflow for rule-based lipid identification using untargeted high-resolution tandem mass spectrometry data</article-title>. <source>BMC Bioinformatics</source>. <year>2017</year>;<volume>18</volume>(<issue>1</issue>):<fpage>331</fpage>. Epub 2017/07/10. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1186/s12859-017-1744-3" ns0:type="simple">10.1186/s12859-017-1744-3</ext-link></comment> <object-id pub-id-type="pmid">28693421</object-id>; PubMed Central PMCID: PMC5504796.</mixed-citation></ref>
<ref id="pone.0222393.ref047"><label>47</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Wulff</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Mitchell</surname> <given-names>MW</given-names></name>. <article-title>A Comparison of Various Normalization Methods for LC/MS Metabolomics Data</article-title>. <source>Scientific Research</source>. <year>2018</year>:<fpage>339</fpage>&#8211;<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.4236/abb.2018.98022" ns0:type="simple">10.4236/abb.2018.98022</ext-link></comment></mixed-citation></ref>
<ref id="pone.0222393.ref048"><label>48</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>van den Berg</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Hoefsloot</surname> <given-names>HC</given-names></name>, <name name-style="western"><surname>Westerhuis</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Smilde</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>van der Werf</surname> <given-names>MJ</given-names></name>. <article-title>Centering, scaling, and transformations: improving the biological information content of metabolomics data</article-title>. <source>BMC Genomics</source>. <year>2006</year>;<volume>7</volume>:<fpage>142</fpage>. Epub 2006/06/08. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1186/1471-2164-7-142" ns0:type="simple">10.1186/1471-2164-7-142</ext-link></comment> <object-id pub-id-type="pmid">16762068</object-id>; PubMed Central PMCID: PMC1534033.</mixed-citation></ref>
<ref id="pone.0222393.ref049"><label>49</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Chong</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Soufan</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Caraus</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bourque</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis</article-title>. <source>Nucleic Acids Res</source>. <year>2018</year>;<volume>46</volume>(<issue>W1</issue>):<fpage>W486</fpage>&#8211;<lpage>W94</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1093/nar/gky310" ns0:type="simple">10.1093/nar/gky310</ext-link></comment> <object-id pub-id-type="pmid">29762782</object-id>; PubMed Central PMCID: PMC6030889.</mixed-citation></ref>
<ref id="pone.0222393.ref050"><label>50</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>HOLM</surname> <given-names>S.</given-names></name> <article-title>A SIMPLE SEQUENTIALLY REJECTIVE MULTIPLE TEST PROCEDURE</article-title>. <source>Scandinavian Journal of Statistics</source>. <year>1979</year>;<volume>6</volume>(<issue>2</issue>):<fpage>65</fpage>&#8211;<lpage>70</lpage>. WOS:A1979JY78700003.</mixed-citation></ref>
<ref id="pone.0222393.ref051"><label>51</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Roa Engel</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Straathof</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Zijlmans</surname> <given-names>TW</given-names></name>, <name name-style="western"><surname>van Gulik</surname> <given-names>WM</given-names></name>, <name name-style="western"><surname>van der Wielen</surname> <given-names>LA</given-names></name>. <article-title>Fumaric acid production by fermentation</article-title>. <source>Appl Microbiol Biotechnol</source>. <year>2008</year>;<volume>78</volume>(<issue>3</issue>):<fpage>379</fpage>&#8211;<lpage>89</lpage>. Epub 2008/01/24. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1007/s00253-007-1341-x" ns0:type="simple">10.1007/s00253-007-1341-x</ext-link></comment> <object-id pub-id-type="pmid">18214471</object-id>; PubMed Central PMCID: PMC2243254.</mixed-citation></ref>
<ref id="pone.0222393.ref052"><label>52</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Breidt</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>P&#233;rez-D&#237;az</surname> <given-names>IM</given-names></name>, <name name-style="western"><surname>Osborne</surname> <given-names>JA</given-names></name>. <article-title>Antimicrobial effects of weak acids on the survival of Escherichia coli O157:H7 under anaerobic conditions</article-title>. <source>J Food Prot</source>. <year>2011</year>;<volume>74</volume>(<issue>6</issue>):<fpage>893</fpage>&#8211;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.4315/0362-028X.JFP-10-404" ns0:type="simple">10.4315/0362-028X.JFP-10-404</ext-link></comment> <object-id pub-id-type="pmid">21669064</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref053"><label>53</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>PODOLAK</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>ZAYAS</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>KASTNER</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>FUNG</surname> <given-names>D</given-names></name>. <article-title>REDUCTION OF LISTERIA-MONOCYTOGENES, ESCHERICHIA-COLI O157-H7 AND SALMONELLA-TYPHIMURIUM DURING STORAGE ON BEEF SANITIZED WITH FUMARIC, ACETIC</article-title>, <source>AND LACTIC ACIDS. Journal of Food Safety</source>. <year>1995</year>;<volume>15</volume>(<issue>3</issue>):<fpage>283</fpage>&#8211;<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1111/j.1745-4565.1995.tb00140.x" ns0:type="simple">10.1111/j.1745-4565.1995.tb00140.x</ext-link></comment> WOS:A1995TE39400007.</mixed-citation></ref>
<ref id="pone.0222393.ref054"><label>54</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Podolak</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Zayas</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kastner</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fung</surname> <given-names>D</given-names></name>. <article-title>Reduction of bacterial populations on vacuum-packaged ground beef patties with fumaric and lactic acids</article-title>. <source>Journal of Food Protection</source>. <year>1996</year>;<volume>59</volume>(<issue>10</issue>):<fpage>1037</fpage>&#8211;<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.4315/0362-028X-59.10.1037" ns0:type="simple">10.4315/0362-028X-59.10.1037</ext-link></comment> WOS:A1996VQ54200003. <object-id pub-id-type="pmid">31195464</object-id></mixed-citation></ref>
<ref id="pone.0222393.ref055"><label>55</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>OREN</surname> <given-names>A.</given-names></name> <article-title>ANAEROBIC GROWTH OF HALOPHILIC ARCHAEOBACTERIA BY REDUCTION OF FUMARATE</article-title>. <source>Journal of General Microbiology</source>. <year>1991</year>;<volume>137</volume>:<fpage>1387</fpage>&#8211;<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1099/00221287-137-6-1387" ns0:type="simple">10.1099/00221287-137-6-1387</ext-link></comment> WOS:A1991FR41100019.</mixed-citation></ref>
<ref id="pone.0222393.ref056"><label>56</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Brooijmans</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>de Vos</surname> <given-names>WM</given-names></name>, <name name-style="western"><surname>Hugenholtz</surname> <given-names>J</given-names></name>. <article-title>Electron transport chains of lactic acid bacteria&#8212;walking on crutches is part of their lifestyle</article-title>. <source>F1000 Biol Rep</source>. <year>2009</year>;<volume>1</volume>:<fpage>34</fpage>. Epub 2009/04/29. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.3410/B1-34" ns0:type="simple">10.3410/B1-34</ext-link></comment> <object-id pub-id-type="pmid">20948651</object-id>; PubMed Central PMCID: PMC2924693.</mixed-citation></ref>
<ref id="pone.0222393.ref057"><label>57</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Max</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Salgado</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Rodr&#237;guez</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Cort&#233;s</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Converti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dom&#237;nguez</surname> <given-names>JM</given-names></name>. <article-title>Biotechnological production of citric acid</article-title>. <source>Braz J Microbiol</source>. <year>2010</year>;<volume>41</volume>(<issue>4</issue>):<fpage>862</fpage>&#8211;<lpage>75</lpage>. Epub 2010/12/01. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1590/S1517-83822010000400005" ns0:type="simple">10.1590/S1517-83822010000400005</ext-link></comment> <object-id pub-id-type="pmid">24031566</object-id>; PubMed Central PMCID: PMC3769771.</mixed-citation></ref>
<ref id="pone.0222393.ref058"><label>58</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>D&#237;az-Mu&#241;iz</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Steele</surname> <given-names>JL</given-names></name>. <article-title>Conditions required for citrate utilization during growth of Lactobacillus casei ATCC334 in chemically defined medium and cheddar cheese extract</article-title>. <source>Antonie Van Leeuwenhoek</source>. <year>2006</year>;<volume>90</volume>(<issue>3</issue>):<fpage>233</fpage>&#8211;<lpage>43</lpage>. Epub 2006/07/14. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1007/s10482-006-9078-6" ns0:type="simple">10.1007/s10482-006-9078-6</ext-link></comment> <object-id pub-id-type="pmid">16841145</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref059"><label>59</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>D&#237;az-Mu&#241;iz</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Banavara</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Budinich</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Rankin</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Dudley</surname> <given-names>EG</given-names></name>, <name name-style="western"><surname>Steele</surname> <given-names>JL</given-names></name>. <article-title>Lactobacillus casei metabolic potential to utilize citrate as an energy source in ripening cheese: a bioinformatics approach</article-title>. <source>J Appl Microbiol</source>. <year>2006</year>;<volume>101</volume>(<issue>4</issue>):<fpage>872</fpage>&#8211;<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1111/j.1365-2672.2006.02965.x" ns0:type="simple">10.1111/j.1365-2672.2006.02965.x</ext-link></comment> <object-id pub-id-type="pmid">16968299</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref060"><label>60</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Branen</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Keenan</surname> <given-names>TW</given-names></name>. <article-title>Growth stimulation of Lactobacillus casei by sodium citrate</article-title>. <source>J Dairy Sci</source>. <year>1970</year>;<volume>53</volume>(<issue>5</issue>):<fpage>593</fpage>&#8211;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.3168/jds.S0022-0302(70)86259-2" ns0:type="simple">10.3168/jds.S0022-0302(70)86259-2</ext-link></comment> <object-id pub-id-type="pmid">5441913</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref061"><label>61</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Branen</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Keenan</surname> <given-names>TW</given-names></name>. <article-title>Effects of citrate on the composition and metabolism of Lactobacillus casei</article-title>. <source>Appl Microbiol</source>. <year>1971</year>;<volume>21</volume>(<issue>6</issue>):<fpage>993</fpage>&#8211;<lpage>8</lpage>. <object-id pub-id-type="pmid">4327613</object-id>; PubMed Central PMCID: PMC377330.</mixed-citation></ref>
<ref id="pone.0222393.ref062"><label>62</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Benito de C&#225;rdenas</surname> <given-names>IL</given-names></name>, <name name-style="western"><surname>Medina</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Oliver</surname> <given-names>G</given-names></name>. [<article-title>Effect of glucose and lactose on the utilization of citrate by Lactobacillus casei subsp. rhamnosus ATCC 7469</article-title>]. <source>Rev Argent Microbiol</source>. <year>1992</year>;<volume>24</volume>(<issue>3&#8211;4</issue>):<fpage>136</fpage>&#8211;<lpage>44</lpage>. <object-id pub-id-type="pmid">1302866</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref063"><label>63</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>D</given-names></name>. <article-title>Polysaccharide monooxygenase-catalyzed oxidation of cellulose to glucuronic acid-containing cello-oligosaccharides</article-title>. <source>Biotechnol Biofuels</source>. <year>2019</year>;<volume>12</volume>:<fpage>42</fpage>. Epub 2019/02/27. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1186/s13068-019-1384-0" ns0:type="simple">10.1186/s13068-019-1384-0</ext-link></comment> <object-id pub-id-type="pmid">30858879</object-id>; PubMed Central PMCID: PMC6391835.</mixed-citation></ref>
<ref id="pone.0222393.ref064"><label>64</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Kaur</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Macleod</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Foley</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Nayudu</surname> <given-names>M</given-names></name>. <article-title>Gluconic acid: an antifungal agent produced by Pseudomonas species in biological control of take-all</article-title>. <source>Phytochemistry</source>. <year>2006</year>;<volume>67</volume>(<issue>6</issue>):<fpage>595</fpage>&#8211;<lpage>604</lpage>. Epub 2006/01/30. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/j.phytochem.2005.12.011" ns0:type="simple">10.1016/j.phytochem.2005.12.011</ext-link></comment> <object-id pub-id-type="pmid">16445952</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref065"><label>65</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Miners</surname> <given-names>JO</given-names></name>, <name name-style="western"><surname>Mackenzie</surname> <given-names>PI</given-names></name>. <article-title>Drug glucuronidation in humans</article-title>. <source>Pharmacol Ther</source>. <year>1991</year>;<volume>51</volume>(<issue>3</issue>):<fpage>347</fpage>&#8211;<lpage>69</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/0163-7258(91)90065-t" ns0:type="simple">10.1016/0163-7258(91)90065-t</ext-link></comment> <object-id pub-id-type="pmid">1792239</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref066"><label>66</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>King</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Rios</surname> <given-names>GR</given-names></name>, <name name-style="western"><surname>Green</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Tephly</surname> <given-names>TR</given-names></name>. <article-title>UDP-glucuronosyltransferases</article-title>. <source>Curr Drug Metab</source>. <year>2000</year>;<volume>1</volume>(<issue>2</issue>):<fpage>143</fpage>&#8211;<lpage>61</lpage>. <object-id pub-id-type="pmid">11465080</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref067"><label>67</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Parsons</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Rock</surname> <given-names>CO</given-names></name>. <article-title>Bacterial lipids: metabolism and membrane homeostasis</article-title>. <source>Prog Lipid Res</source>. <year>2013</year>;<volume>52</volume>(<issue>3</issue>):<fpage>249</fpage>&#8211;<lpage>76</lpage>. Epub 2013/03/14. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/j.plipres.2013.02.002" ns0:type="simple">10.1016/j.plipres.2013.02.002</ext-link></comment> <object-id pub-id-type="pmid">23500459</object-id>; PubMed Central PMCID: PMC3665635.</mixed-citation></ref>
<ref id="pone.0222393.ref068"><label>68</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Sengupta</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Altermann</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>McNabb</surname> <given-names>WC</given-names></name>, <name name-style="western"><surname>Moughan</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Roy</surname> <given-names>NC</given-names></name>. <article-title>The role of cell surface architecture of lactobacilli in host-microbe interactions in the gastrointestinal tract</article-title>. <source>Mediators Inflamm</source>. <year>2013</year>;<volume>2013</volume>:<fpage>237921</fpage>. Epub 2013/03/13. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1155/2013/237921" ns0:type="simple">10.1155/2013/237921</ext-link></comment> <object-id pub-id-type="pmid">23576850</object-id>; PubMed Central PMCID: PMC3610365.</mixed-citation></ref>
<ref id="pone.0222393.ref069"><label>69</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Guerzoni</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Lanciotti</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Cocconcelli</surname> <given-names>PS</given-names></name>. <article-title>Alteration in cellular fatty acid composition as a response to salt, acid, oxidative and thermal stresses in Lactobacillus helveticus</article-title>. <source>Microbiology</source>. <year>2001</year>;<volume>147</volume>(<issue>Pt 8</issue>):<fpage>2255</fpage>&#8211;<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1099/00221287-147-8-2255" ns0:type="simple">10.1099/00221287-147-8-2255</ext-link></comment> <object-id pub-id-type="pmid">11496002</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref070"><label>70</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Taranto</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Fernandez Murga</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Lorca</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>de Valdez</surname> <given-names>GF</given-names></name>. <article-title>Bile salts and cholesterol induce changes in the lipid cell membrane of Lactobacillus reuteri</article-title>. <source>J Appl Microbiol</source>. <year>2003</year>;<volume>95</volume>(<issue>1</issue>):<fpage>86</fpage>&#8211;<lpage>91</lpage>. <object-id pub-id-type="pmid">12807457</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref071"><label>71</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Fozo</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Kajfasz</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Quivey</surname> <given-names>RG</given-names></name>. <article-title>Low pH-induced membrane fatty acid alterations in oral bacteria</article-title>. <source>FEMS Microbiol Lett</source>. <year>2004</year>;<volume>238</volume>(<issue>2</issue>):<fpage>291</fpage>&#8211;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1016/j.femsle.2004.07.047" ns0:type="simple">10.1016/j.femsle.2004.07.047</ext-link></comment> <object-id pub-id-type="pmid">15358413</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref072"><label>72</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>Artis</surname> <given-names>D.</given-names></name> <article-title>Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut</article-title>. <source>Nat Rev Immunol</source>. <year>2008</year>;<volume>8</volume>(<issue>6</issue>):<fpage>411</fpage>&#8211;<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" ns0:href="https://doi.org/10.1038/nri2316" ns0:type="simple">10.1038/nri2316</ext-link></comment> <object-id pub-id-type="pmid">18469830</object-id>.</mixed-citation></ref>
<ref id="pone.0222393.ref073"><label>73</label><mixed-citation publication-type="journal" ns0:type="simple"><name name-style="western"><surname>HAYAISHI</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>JAKOBY</surname> <given-names>WB</given-names></name>, <name name-style="western"><surname>OHMURA</surname> <given-names>E</given-names></name>. <article-title>Enzymatic decarboxylation of oxalic acid</article-title>. <source>J Biol Chem</source>. <year>1956</year>;<volume>222</volume>(<issue>1</issue>):<fpage>435</fpage>&#8211;<lpage>46</lpage>. <object-id pub-id-type="pmid">13367015</object-id>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article article-type="aggregated-review-documents" id="pone.0222393.r001" specific-use="decision-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0222393.r001</article-id>
<title-group>
<article-title>Decision Letter 0</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Motta</surname>
<given-names>Andrea</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2019</copyright-year>
<copyright-holder>Andrea Motta</copyright-holder>
<license ns0:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" ns0:href="http://creativecommons.org/licenses/by/4.0/" ns0:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pone.0222393" document-id-type="doi" document-type="article" id="rel-obj001" link-type="peer-reviewed-article" />
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>0</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">18 Aug 2019</named-content>
</p>
<p>PONE-D-19-20190</p>
<p>Metabolomic Profiling of Oxalate-Degrading Probiotic Lactobacillus acidophilus and Lactobacillus gasseri</p>
<p>PLOS ONE</p>
<p>Dear Dr. Garrett,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#8217;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Both reviewers reported that the manuscript is interesting and well written. The authors are required to discuss the minor points raised by the reviewers.</p>
<p>We would appreciate receiving your revised manuscript by Oct 02 2019 11:59PM. When you are ready to submit your revision, log on to <ext-link ext-link-type="uri" ns0:href="https://www.editorialmanager.com/pone/" ns0:type="simple">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.</p>
<p>To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <ext-link ext-link-type="uri" ns0:href="http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ns0:type="simple">http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link></p>
<p>Please include the following items when submitting your revised manuscript:</p>
<p><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.</p></list-item></list></p>
<p>Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Andrea Motta</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>When submitting your revision, we need you to address these additional requirements.</p>
<p>Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
<p><ext-link ext-link-type="uri" ns0:href="http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ns0:type="simple">http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and <ext-link ext-link-type="uri" ns0:href="http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ns0:type="simple">http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link></p>
<p>1. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.</p>
<p>2. Please include a copy of Table 2 which you refer to in your text on page 15</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p><bold>Comments to the Author</bold></p>
<p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>2. Has the statistical analysis been performed appropriately and rigorously? </p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
<p>The <ext-link ext-link-type="uri" ns0:href="http://www.plosone.org/static/policies.action#sharing" ns0:type="simple">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#8212;e.g. participant privacy or use of data from a third party&#8212;those must be specified.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>5. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #1: In Methods</p>
<p>The authors should better clarify the storage times, were the bacterial lysates stored at -80 &#176; C for how long before the analysis?</p>
<p>Was the storage time the same for all the samples analyzed in this work?</p>
<p>The authors compare the metabolic profiles between the two bacterial strains grown in a medium supplemented with oxalate (20 mM), they believe that it is not necessary to carry out controls on cultures not supplemented with oxalate? Or have they already performed these experiments in the past?</p>
<p>The description of lipid extraction should be improved</p>
<p>Reviewer #2: In the manuscript by Chamberlain et al, the authors deal focus on the metabolomes and lipidome of the oxalate-degrading Lactobacillus acidophilus and Lactobacillus gasseri. These studies might be important to define the metabolic properties of Lactobacillus that allow these bacteria to interact with the host intestine and influence overall health</p>
<p>The studies are well designed and data presented clearly. There are some issues that will need to be addressed prior to publication, however</p>
<p>The authors should explain for how long the bacterial lysates were stored at -80 &#176; C? before analysis</p>
<p>Have the authors performed the metabolic profiles also on cultures not supplemented with oxalate?</p>
<p>**********</p>
<p>6. PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" ns0:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ns0:type="simple">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
<p>If you choose &#8220;no&#8221;, your identity will remain anonymous but your review may still be made public.</p>
<p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" ns0:href="https://www.plos.org/privacy-policy" ns0:type="simple">Privacy Policy</ext-link>.</p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: No</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link ext-link-type="uri" ns0:href="https://pacev2.apexcovantage.com/" ns0:type="simple">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email ns0:type="simple">figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
</body>
</sub-article>
<sub-article article-type="author-comment" id="pone.0222393.r002">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0222393.r002</article-id>
<title-group>
<article-title>Author response to Decision Letter 0</article-title>
</title-group>
<related-object document-id="10.1371/journal.pone.0222393" document-id-type="doi" document-type="peer-reviewed-article" id="rel-obj002" link-type="rebutted-decision-letter" object-id="10.1371/journal.pone.0222393.r001" object-id-type="doi" object-type="decision-letter" />
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>1</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="author-response-date">22 Aug 2019</named-content>
</p>
<p>Reviewer 1:</p>
<p>Comment:</p>
<p>Comment #1: The authors should better clarify the storage times, were the bacterial lysates stored at -80 &#176; C for how long before the analysis?</p>
<p>Thank you for your feedback. The lysates were only stored for a brief time (approximately 1 month) before extraction, a time which was consistent across all samples. In our experience, lysates of this nature suspended in KH2PO4-based lysis buffer are stable for metabolomics analyses for several years, so we are confident that this short storage period is inconsequential to the experiment. We have adjusted the text (highlighted below) as follows to make this more clear to the reader.</p>
<p>&#8220;Cell lysates were immediately frozen at -80 &#176;C to ensure their stability and were briefly held frozen (approximately 1 month) until needed for extraction, all samples being stored for an equal period of time. In our experience, lysates of this nature suspended in KH2PO4-based lysis buffer are stable for metabolomics analyses for several years.&#8221;</p>
<p>Comment #2: Was the storage time the same for all the samples analyzed in this work?</p>
<p>Thank you for your feedback. Yes, the storage time was the sample for all samples analyzed in this work. Please see our response to Comment #1 in which we clarify this point in the adjusted text.</p>
<p>Comment #3: The authors compare the metabolic profiles between the two bacterial strains grown in a medium supplemented with oxalate (20 mM), they believe that it is not necessary to carry out controls on cultures not supplemented with oxalate? Or have they already performed these experiments in the past?</p>
<p>Thank you for your feedback. The purpose of this experiment was to profile and compare the metabolomes of L. acidophilus and L. gasseri, not necessarily to compare the metabolomes in an oxalate versus non-oxalate environment. Oxalate was included in the media simply because that is how we have historically cultured Lactobacillus, but it will grow in many different types of media so it is difficult to assign one media as its native environment. Therefore, we did not perform an analysis on Lactobacillus grown without oxalate since such a control was outside of the focus of this experiment. </p>
<p>It would be interesting for future studies to compare how the metabolome of Lactobacillus changes in different types of media, but being that it grows in many different matrices, it would be difficult to establish what is the &#8220;native&#8221; media since there is no designated media that puts it into its native state. </p>
<p>Comment #4: The description of lipid extraction should be improved.</p>
<p>Thank you for your feedback. We believe there may be some confusion that the lipid extraction was not explained given the placement of references to the Folch method and our previous work at the beginning of the Lipid Extraction section. Immediately following this first sentence, the lipid extraction is explained in significant detail. To make this more clear to the reader, we have inserted text (highlighted below) that indicates the beginning of the description of the lipid extraction.</p>
<p>&#8220;Lipids were extracted using a modified version of the Folch method (41) similarly to our previous work (38) using the following process which we describe in detail here. From each normalized cell lysate sample, 150 &#181;L was transferred to a 12 mL glass vial. Extraction blanks were included for downstream data filtering using 150 &#181;L lysis buffer and were treated identically to biological samples. To each sample, 20 &#956;L of internal standard mix (Avanti Polar Lipids, Alabaster, AL, USA) was added followed by brief vortexing &#8211; LPC(17:0), PC(17:0/17:0), PG(14:0/14:0), PE(15:0/15:0), PS(14:0/14:0), TG(15:0/15:0/15:0), PI(8:0), SM(d18:1/17:0), CER(d18:1/17:0), DG(14:0/14:0), CL(15:0(3)-16:1), SO(d17:1), PAzePC, CER(Glycosyl(&#946;) C12), BMP(14:0 (S,R)), LSM(d17:1), 5 &#956;g/mL each in 2:1 chloroform:methanol. Next, 400 &#956;L methanol was added to each sample followed by vortexing, then 800 &#956;L chloroform was added. Samples were vortexed and incubated on ice for 20 min, with vortexing at 10 and 20 min, followed by addition of 200 &#956;L water. Samples were briefly vortexed and incubated on ice for 10 min with vortexing at 5 and 10 min. Separation of the organic and aqueous layers was achieved by centrifugation at 3260&#215;g, 4&#176;C for 10 min. The organic (bottom) layer containing lipid content was transferred to a new 12 mL glass vial in two steps: first with removal of 800 &#956;L of the original organic layer, followed by another removal of 400 &#956;L after re-extracting the remaining aqueous layer with 400 &#956;L 2:1 chloroform:methanol by incubating on ice for 10 min and centrifugation at 3260&#215;g, 4&#176;C for 10 min. Lipid extracts were dried under nitrogen at 30&#176;C and reconstituted in 300 &#956;L isopropanol. Samples were centrifuged at 3260&#215;g, 4&#176;C for 10 min to pellet any residual protein, and 250 &#956;L supernatants were transferred to glass LC vials for UHPLC-HRMS analysis.&#8221;</p>
<p>Reviewer 2: </p>
<p>Comment #1: The authors should explain for how long the bacterial lysates were stored at -80 &#176; C before analysis?</p>
<p>Thank you for your feedback. Please see our response to Reviewer 1 Comments #1 and #2, which addresses these same questions.</p>
<p>Comment #2: Have the authors performed the metabolic profiles also on cultures not supplemented with oxalate?</p>
<p>Thank you for your feedback. Please see our response to Reviewer 1 Comment #3, which addresses this same question.</p>
</body>
</sub-article>
<sub-article article-type="editor-report" id="pone.0222393.r003" specific-use="decision-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0222393.r003</article-id>
<title-group>
<article-title>Decision Letter 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Motta</surname>
<given-names>Andrea</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2019</copyright-year>
<copyright-holder>Andrea Motta</copyright-holder>
<license ns0:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" ns0:href="http://creativecommons.org/licenses/by/4.0/" ns0:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pone.0222393" document-id-type="doi" document-type="article" id="rel-obj003" link-type="peer-reviewed-article" />
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>1</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">29 Aug 2019</named-content>
</p>
<p>Metabolomic Profiling of Oxalate-Degrading Probiotic Lactobacillus acidophilus and Lactobacillus gasseri</p>
<p>PONE-D-19-20190R1</p>
<p>Dear Dr. Garrett,</p>
<p>We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.</p>
<p>Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.</p>
<p>Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <ext-link ext-link-type="uri" ns0:href="https://www.editorialmanager.com/pone/" ns0:type="simple">https://www.editorialmanager.com/pone/</ext-link>, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <email ns0:type="simple">authorbilling@plos.org</email>.</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email ns0:type="simple">onepress@plos.org</email>.</p>
<p>With kind regards,</p>
<p>Andrea Motta</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Additional Editor Comments (optional):</p>
<p>All comments have been addressed.</p>
<p>Reviewers' comments:</p>
</body>
</sub-article>
<sub-article article-type="editor-report" id="pone.0222393.r004" specific-use="acceptance-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0222393.r004</article-id>
<title-group>
<article-title>Acceptance letter</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Motta</surname>
<given-names>Andrea</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2019</copyright-year>
<copyright-holder>Andrea Motta</copyright-holder>
<license ns0:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" ns0:href="http://creativecommons.org/licenses/by/4.0/" ns0:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pone.0222393" document-id-type="doi" document-type="article" id="rel-obj004" link-type="peer-reviewed-article" />
</front-stub>
<body>
<p>
<named-content content-type="letter-date">13 Sep 2019</named-content>
</p>
<p>PONE-D-19-20190R1 </p>
<p>Metabolomic Profiling of Oxalate-Degrading Probiotic <italic>Lactobacillus acidophilus</italic> and <italic>Lactobacillus gasseri</italic> </p>
<p>Dear Dr. Garrett:</p>
<p>I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email ns0:type="simple">onepress@plos.org</email>.</p>
<p>For any other questions or concerns, please email <email ns0:type="simple">plosone@plos.org</email>. </p>
<p>Thank you for submitting your work to PLOS ONE.</p>
<p>With kind regards,</p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Dr. Andrea Motta  </p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
</body>
</sub-article>
</article>